Cerebrolysin Peptide research-grade
Cerebrolysin Peptide

Cerebrolysin Peptide

$99.00

Research-grade Cerebrolysin Peptide for laboratory investigation. For Research Use Only. Not for human use.

For Research Use Only — Not for Human Consumption
Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Checkout

Accepted Payment Methods

For Research Use Only. Not for human use.

Cerebrolysin Peptide research-grade

Overview

Cerebrolysin Peptide is supplied as a research-grade catalog material for controlled laboratory investigation.

Laboratories choose this item when protocols need clear identification, consistent labeling, and documentation suitable for reproducible experimental workflows.

Catalog packaging and research-use labeling help purchasing and bench teams keep procurement records aligned with the physical vial.

Research Context for Cerebrolysin Peptide

Work involving Cerebrolysin Peptide typically focuses on in vitro systems, assay development, and mechanistic model studies.

Teams confirm lot details before setup so conditions stay traceable across repeats and collaborative sites.

Published literature can inform starting ranges for related experimental designs. Each laboratory should still validate performance with its own instruments, plates, and detection chemistry.

Pilot runs are useful before committing larger plate sets, especially when detection chemistry or incubation windows are being optimized.

Documented Attributes

Key catalog attributes for this material include:

  • Research-grade material intended for laboratory investigation only
  • Catalog labeling aligned with research procurement channels
  • Suitable for method development and comparative assay workflows
  • Documentation packages available where provided for the listed lot

Laboratory Handling Notes

Receiving and Identity Checks

Before opening a vial of Cerebrolysin Peptide, confirm the physical label against the purchase order and packing list.

Retain outer packaging until identity checks are complete, and report damaged seals to purchasing before experimental work continues.

Reconstitution and Aliquoting

Handle this material according to institutional SOPs for weighing, reconstitution, aliquoting, and storage.

Record lot identifiers in laboratory notebooks before reconstitution. Verify solvent compatibility and storage temperature against your validated process.

Prepare assay buffers and consumables before opening the vial to reduce hold time. Keep unused aliquots labeled with date, solvent, and concentration for later repeats.

Chain of Custody

Keep chain-of-custody notes with inventory checks when material moves between freezers or benches.

Use dedicated spatulas and clean balances to avoid cross-contamination between catalog items. Schedule thaw cycles intentionally rather than repeated freeze-thaw of the same aliquot.

Secondary containment trays reduce spill risk during multi-step reconstitution. Cold-chain interruptions should be noted even when the vial remains sealed.

Why Laboratories Source Cerebrolysin Peptide

Procurement and research teams often select this catalog item because it supports:

  • Clear research-use labeling for compliance-aligned purchasing
  • Consistent product identification across multi-lot studies
  • Fit for reference, screening, and mechanistic laboratory models
  • Straightforward catalog support for planning and documentation

Study Planning and Quality Documentation

Before starting experimental work with Cerebrolysin Peptide, review any COA or quality files provided with the shipment.

Align your protocol with institutional research requirements and keep use within the labeled research context.

File catalog documentation with the study records at receipt. These steps help keep experiments comparable over time when using Cerebrolysin Peptide in sequential study phases.

Method Development Tips

Method development often begins with small pilot plates before larger screening panels.

Document buffer lots, incubation times, and detection settings alongside the material lot number.

If results diverge from historical baselines, re-check reconstitution volume and storage history first. Shared equipment logs help explain variance when multiple operators run the same protocol.

Inventory and Training

Update digital inventory immediately after opening a new lot of Cerebrolysin Peptide.

Training new staff on labeling conventions reduces mix-ups across similar catalog SKUs. When transferring methods between sites, share both the written SOP and the lot metadata package.

Dispose of residual solutions according to institutional chemical hygiene rules. Do not repurpose research materials for any non-laboratory application.

Periodic inventory reconciliation keeps expired or depleted lots from entering active workflows. For related catalog options, browse adjacent research categories on this site after confirming your assay needs.

For Research Use Only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease.

Peptide Research

For Research Use Only. Not for human use.

PubMed (NIH/NLM) records related to this compound for laboratory literature review. Inclusion does not imply suitability for any use beyond controlled research. Each note below is a research-framed summary using compliance-safe wording.

Showing 438 PubMed records. Displaying 10 per page.

  1. Ziganshina LE et al. (2023). Laboratory research record on Cerebrolysin [PMID: 37818733]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  2. Cui S et al. (2019). Cerebrolysin for vascular dementia [PMID: 31710397]

    Laboratory literature summary: Cerebrolysin for vascular dementia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  3. Ziganshina LE et al. (2015). Laboratory research record on Cerebrolysin [PMID: 26083192]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  4. Ziganshina LE et al. (2017). Laboratory research record on Cerebrolysin [PMID: 28430363]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  5. Ziganshina LE et al. (2020). Laboratory research record on Cerebrolysin [PMID: 32662068]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  6. Chen N et al. (2013). Cerebrolysin for vascular dementia [PMID: 23440834]

    Laboratory literature summary: Cerebrolysin for vascular dementia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  7. Torshin IY et al. (2019). [Cerebrolysin peptides as mood stabilizers] [PMID: 31994517]

    Laboratory literature summary: [Cerebrolysin peptides as mood stabilizers]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  8. Plosker GL et al. (2009). Cerebrolysin: a review of its use in dementia [PMID: 19848437]

    Laboratory literature summary: Cerebrolysin: a review of its use in dementia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  9. Ziganshina LE et al. (2016). Laboratory research record on Cerebrolysin [PMID: 27918088]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  10. Ziganshina LE et al. (2010). Laboratory research record on Cerebrolysin [PMID: 20393954]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  11. Antón Álvarez X et al. (2011). Cerebrolysin in neurodegeneration research models's disease [PMID: 22013558]

    Laboratory literature summary: Cerebrolysin in neurodegeneration research models's disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  12. Brainin M (2018). Laboratory research record on Cerebrolysin [PMID: 30004268]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  13. iganshina LE et al. (2013). Laboratory research record on Cerebrolysin [PMID: 23805635]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  14. Sharma HS et al. (2016). Neurodegeneration research models's disease: cerebrolysin and nanotechnology as a… [PMID: 27827552]

    Laboratory literature summary: neurodegeneration research models's disease: cerebrolysin and nanotechnology as a investigational strategy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  15. Jarosz K et al. (2023). Cerebrolysin in research subjects with TBI: Systematic Review and Meta-Analysis [PMID: 36979317]

    Laboratory literature summary: Cerebrolysin in research subjects with TBI: Systematic Review and Meta-Analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  16. Trimmel H et al. (2024). Life-Threatening Anaphylaxis due to Cerebrolysin® [PMID: 39055722]

    Laboratory literature summary: Life-Threatening Anaphylaxis due to Cerebrolysin®. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  17. Villarreal-Reyna G et al. (2022). Cerebrolysin induces hair repigmentation associated to MART-1/Melan-A reactivation [PMID: 36411485]

    Laboratory literature summary: Cerebrolysin induces hair repigmentation associated to MART-1/Melan-A reactivation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  18. Bogolepova AN (2023). [Cerebrolysin in the investigation of cognitive impairment] [PMID: 36946392]

    Laboratory literature summary: [Cerebrolysin in the investigation of cognitive impairment]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  19. Florek S et al. (2025). Is Cerebrolysin Useful in Psychiatry Disorders? [PMID: 40722733]

    Laboratory literature summary: Is Cerebrolysin Useful in Psychiatry Disorders?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  20. Plosker GL et al. (2010). Spotlight on cerebrolysin in dementia [PMID: 20155999]

    Laboratory literature summary: Spotlight on cerebrolysin in dementia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  21. Ribó M et al. (2026). Laboratory research record on Cerebrolysin [PMID: 41349847]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  22. Sarode LP et al. (2023). Cerebrolysin reduces excitotoxicity by modulation of cell-death proteins in delayed… [PMID: 37273080]

    Laboratory literature summary: Cerebrolysin reduces excitotoxicity by modulation of cell-death proteins in delayed hours of ischemic reperfusion injury. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  23. Homberg V et al. (2025). Laboratory research record on Cerebrolysin [PMID: 39957612]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  24. Ozkizilcik A et al. (2019). Nanodelivery of cerebrolysin reduces pathophysiology of neurodegeneration research… [PMID: 30961868]

    Laboratory literature summary: Nanodelivery of cerebrolysin reduces pathophysiology of neurodegeneration research models's disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  25. Morega S et al. (2022). Cerebrolysin Use in research subjects with Liver Damage-A Translational Study [PMID: 36362945]

    Laboratory literature summary: Cerebrolysin Use in research subjects with Liver Damage-A Translational Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  26. Kojder K et al. (2023). Cerebrolysin in research subjects with Subarachnoid Hemorrhage: A Systematic Review… [PMID: 37892776]

    Laboratory literature summary: Cerebrolysin in research subjects with Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  27. Staszewski J et al. (2025). Laboratory research record on Cerebrolysin [PMID: 40325343]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  28. Fiani B et al. (2021). Laboratory research record on Cerebrolysin [PMID: 33515100]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  29. Aguilar-Hernández L et al. (2025). Cerebrolysin Ameliorates Age-Induced Dendritic Spine Degeneration and Memory Decline… [PMID: 41460391]

    Laboratory literature summary: Cerebrolysin Ameliorates Age-Induced Dendritic Spine Degeneration and Memory Decline in C57BL6 Mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  30. Vosko MR et al. (2025). Laboratory research record on Cerebrolysin [PMID: 40851188]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  31. Mureșanu DF et al. (2022). Laboratory research record on Cerebrolysin [PMID: 35268364]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  32. Gauthier S et al. (2015). Laboratory research record on Cerebrolysin [PMID: 25832905]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  33. Patel PN et al. (2025). Laboratory research record on Cerebrolysin [PMID: 41018475]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  34. Wang Z et al. (2017). Laboratory research record on Cerebrolysin [PMID: 28458521]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  35. Vester JC et al. (2021). Cerebrolysin after moderate to severe traumatic brain injury: prospective… [PMID: 33620612]

    Laboratory literature summary: Cerebrolysin after moderate to severe traumatic brain injury: prospective meta-analysis of the CAPTAIN trial series. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  36. Avci S et al. (2022). Cerebrolysin Alleviating Effect on Glutamate-Mediated Neuroinflammation Via Glutamate… [PMID: 36333611]

    Laboratory literature summary: Cerebrolysin Alleviating Effect on Glutamate-Mediated Neuroinflammation Via Glutamate Transporters and Oxidative Stress. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  37. Allegri RF et al. (2012). Laboratory research record on Cerebrolysin [PMID: 22514793]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  38. Fiani B et al. (2021). Neuroprotective strategies of cerebrolysin for the investigation of infants with… [PMID: 34494216]

    Laboratory literature summary: Neuroprotective strategies of cerebrolysin for the investigation of infants with neonatal hypoxic-ischemic encephalopathy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  39. Thome J et al. (2012). Laboratory research record on Cerebrolysin [PMID: 22514795]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  40. Zhang D et al. (2017). Laboratory research record on Cerebrolysin [PMID: 28656143]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  41. Sharma HS et al. (2019). Nanowired delivery of cerebrolysin with neprilysin and p-Tau antibodies induces… [PMID: 30961867]

    Laboratory literature summary: Nanowired delivery of cerebrolysin with neprilysin and p-Tau antibodies induces superior neuroprotection in neurodegeneration research…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  42. Rejdak K et al. (2023). Laboratory research record on Cerebrolysin [PMID: 37052231]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  43. Kojder K et al. (2024). Cerebrolysin in research subjects analytical assessment with Subarachnoid… [PMID: 39595058]

    Laboratory literature summary: Cerebrolysin in research subjects analytical assessment with Subarachnoid Hemorrhage-The Results of an Observational Cohort Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  44. Bereczki D (2017). Laboratory research record on Cerebrolysin [PMID: 28747461]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  45. Guekht A et al. (2017). Laboratory research record on Cerebrolysin [PMID: 28707130]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  46. Tonge C et al. (2023). Cerebrolysin Amelioration of Spinal Cord Ischemia/ Reperfusion Injury in Rabbit Model [PMID: 37309634]

    Laboratory literature summary: Cerebrolysin Amelioration of Spinal Cord Ischemia/ Reperfusion Injury in Rabbit Model. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  47. Gromova OA et al. (2016). [Evaluation of the antitumor potential of cerebrolysin] [PMID: 28091504]

    Laboratory literature summary: [Evaluation of the antitumor potential of cerebrolysin]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  48. Strilciuc S et al. (2023). Laboratory research record on Cerebrolysin [PMID: 37239783]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  49. Strilciuc S et al. (2021). Laboratory research record on Cerebrolysin [PMID: 34959697]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  50. Wei ZH et al. (2007). Meta-analysis: the observed endpoints of nootropic agent Cerebrolysin in the… [PMID: 17318304]

    Laboratory literature summary: Meta-analysis: the observed endpoints of nootropic agent Cerebrolysin in the investigation of neurodegeneration research models's disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  51. Abdelaty AO et al. (2024). Cerebrolysin potentiates the antidepressant effect of lithium in a rat model of depression [PMID: 38394763]

    Laboratory literature summary: Cerebrolysin potentiates the antidepressant effect of lithium in a rat model of depression. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  52. Yazar U et al. (2023). Cerebrolysin provides effective protection on high glucose-induced neuropathy in… [PMID: 38079610]

    Laboratory literature summary: Cerebrolysin provides effective protection on high glucose-induced neuropathy in cultured rat dorsal root ganglion neurons. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  53. Tran L et al. (2022). Laboratory research record on Cerebrolysin [PMID: 34414874]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  54. Hartwig K et al. (2014). Cerebrolysin protects PC12 cells from CoCl2-induced hypoxia employing GSK3β signaling [PMID: 25093704]

    Laboratory literature summary: Cerebrolysin protects PC12 cells from CoCl2-induced hypoxia employing GSK3β signaling. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  55. Bornstein NM et al. (2018). Laboratory research record on Cerebrolysin [PMID: 29248999]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  56. Zhang Y et al. (2019). Cerebrolysin Reduces Astrogliosis and Axonal Injury and Enhances Neurogenesis in Rats… [PMID: 30499355]

    Laboratory literature summary: Cerebrolysin Reduces Astrogliosis and Axonal Injury and Enhances Neurogenesis in Rats After Closed Head Injury. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  57. Kastberger B et al. (2024). Investigation with Cerebrolysin Prolongs Lifespan in a Mouse Model of Cerebral… [PMID: 38062874]

    Laboratory literature summary: investigation with Cerebrolysin Prolongs Lifespan in a Mouse Model of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  58. Wan M et al. (2024). Laboratory research record on Cerebrolysin [PMID: 38552072]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  59. Kang DH et al. (2020). Effects of Cerebrolysin on Hippocampal Neuronal Death After Pilocarpine-Induced Seizure [PMID: 33177978]

    Laboratory literature summary: Effects of Cerebrolysin on Hippocampal Neuronal Death After Pilocarpine-Induced Seizure. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  60. Abolhasanpour N et al. (2019). Effect of cerebrolysin on bladder function after spinal cord injury in research models… [PMID: 31317583]

    Laboratory literature summary: Effect of cerebrolysin on bladder function after spinal cord injury in research models Wistar rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  61. Zhang Y et al. (2015). Cerebrolysin improves cognitive performance in rats after mild traumatic brain injury [PMID: 25614944]

    Laboratory literature summary: Cerebrolysin improves cognitive performance in rats after mild traumatic brain injury. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  62. Mafikandi V et al. (2025). Effects of cerebrolysin on behavioral changes and the tryptophan-kynurenine pathway in… [PMID: 40668305]

    Laboratory literature summary: Effects of cerebrolysin on behavioral changes and the tryptophan-kynurenine pathway in the prefrontal cortex of research models mice in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  63. Alzoubi KH et al. (2020). Cerebrolysin prevents sleep deprivation induced memory impairment and oxidative stress [PMID: 31987894]

    Laboratory literature summary: Cerebrolysin prevents sleep deprivation induced memory impairment and oxidative stress. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  64. Verisezan Rosu O et al. (2023). Laboratory research record on Cerebrolysin [PMID: 37360156]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  65. Petrukhin AS et al. (2014). [Cerebrolysin in pediatric neurology practice] [PMID: 24637827]

    Laboratory literature summary: [Cerebrolysin in pediatric neurology practice]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  66. Sharma A et al. (2023). Nanowired Delivery of Cerebrolysin Together with Antibodies to Amyloid Beta Peptide,… [PMID: 37480458]

    Laboratory literature summary: Nanowired Delivery of Cerebrolysin Together with Antibodies to Amyloid Beta Peptide, Phosphorylated Tau, and oncology research models…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  67. Lucena LLN et al. (2022). Effect of Cerebrolysin in severe traumatic brain injury: A multi-center, retrospective… [PMID: 35344761]

    Laboratory literature summary: Effect of Cerebrolysin in severe traumatic brain injury: A multi-center, retrospective cohort study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  68. Al-Kuraishy HM et al. (2025). The possible role of cerebrolysin in the management of vascular dementia: Leveraging… [PMID: 39832667]

    Laboratory literature summary: The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  69. Markus HS (2025). Laboratory research record on Cerebrolysin [PMID: 41126602]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  70. Kalinin MN et al. (2024). Laboratory research record on Cerebrolysin [PMID: 38512096]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  71. Menon PK et al. (2017). Intravenous Administration of Functionalized Magnetic Iron Oxide Nanoparticles Does… [PMID: 29132543]

    Laboratory literature summary: Intravenous Administration of Functionalized Magnetic Iron Oxide Nanoparticles Does Not Induce CNS Injury in the Rat: Influence of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  72. Molloy DW et al. (2000). Laboratory experience with Cerebrolysin [PMID: 10961441]

    Laboratory literature summary: laboratory experience with Cerebrolysin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  73. Muresanu DF et al. (2016). Laboratory research record on Cerebrolysin [PMID: 26564102]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  74. Soto C et al. (2023). A retrospective study of Cerebrolysin in research subjects with moderate to severe… [PMID: 37900065]

    Laboratory literature summary: A retrospective study of Cerebrolysin in research subjects with moderate to severe traumatic brain injury: Cognitive and functional outcomes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  75. Keilhoff G et al. (2014). Effects of cerebrolysin on motor-neuron-like NSC-34 cells [PMID: 24997385]

    Laboratory literature summary: Effects of cerebrolysin on motor-neuron-like NSC-34 cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  76. Khasanova DR et al. (2023). Laboratory research record on Cerebrolysin [PMID: 36973684]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  77. Flores-Páez LA et al. (2020). Cerebrolysin enhances the expression of the synaptogenic protein LRRTM4 in the… [PMID: 31850962]

    Laboratory literature summary: Cerebrolysin enhances the expression of the synaptogenic protein LRRTM4 in the hippocampus and improves learning and memory in senescent…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  78. Samir A et al. (2022). Laboratory research record on Cerebrolysin [PMID: 33935111]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  79. Sharma HS et al. (2023). Cerebrolysin Attenuates Exacerbation of Neuropathic Pain, Blood-spinal Cord Barrier… [PMID: 36719560]

    Laboratory literature summary: Cerebrolysin Attenuates Exacerbation of Neuropathic Pain, Blood-spinal Cord Barrier Breakdown and Cord Pathology Following Chronic…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  80. Aguilar-Hernández L et al. (2020). Cerebrolysin ameliorates prefrontal cortex and hippocampus neural atrophy of… [PMID: 32232874]

    Laboratory literature summary: Cerebrolysin ameliorates prefrontal cortex and hippocampus neural atrophy of spontaneous hypertensive rats with hyperglycemia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  81. Ozkizilcik A et al. (2023). Nanowired delivery of antibodies to tau and neuronal nitric oxide synthase together… [PMID: 37783564]

    Laboratory literature summary: Nanowired delivery of antibodies to tau and neuronal nitric oxide synthase together with cerebrolysin attenuates traumatic brain injury…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  82. DeBoer SR et al. (2021). Laboratory research record on Cerebrolysin [PMID: 33955296]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  83. Gavrilova SI et al. (2021). Cerebrolysin in the research protocol of mild cognitive impairment and dementia due to… [PMID: 32808294]

    Laboratory literature summary: Cerebrolysin in the research protocol of mild cognitive impairment and dementia due to neurodegeneration research models's disease: 30…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  84. Morales-Medina JC et al. (2017). Cerebrolysin reduces mechanical allodynia in a rodent model of peripheral inflammation [PMID: 28131658]

    Laboratory literature summary: Cerebrolysin reduces mechanical allodynia in a rodent model of peripheral inflammation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  85. Firstenfeld AJ et al. (2023). Laboratory research record on Cerebrolysin [PMID: 38585517]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  86. Chang WH et al. (2016). Laboratory research record on Cerebrolysin [PMID: 26934986]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  87. Sharma HS et al. (2023). Neuroprotective Effects of Nanowired Delivery of Cerebrolysin with Mesenchymal Stem… [PMID: 37480461]

    Laboratory literature summary: Neuroprotective Effects of Nanowired Delivery of Cerebrolysin with Mesenchymal Stem Cells and Monoclonal Antibodies to Neuronal Nitric…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  88. Martínez-Torres NI et al. (2024). Cerebrolysin Induces Motor Recovery Along with Plastic Changes in Motoneurons and an… [PMID: 39580783]

    Laboratory literature summary: Cerebrolysin Induces Motor Recovery Along with Plastic Changes in Motoneurons and an Increase in GAP43 Protein in the Ventral Spinal…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  89. Seidl LF et al. (2024). Comparing the biological activity and composition of Cerebrolysin with other peptide… [PMID: 38737662]

    Laboratory literature summary: Comparing the biological activity and composition of Cerebrolysin with other peptide preparations. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  90. Catalin B et al. (2018). Laboratory research record on Cerebrolysin [PMID: 29692268]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  91. Menon PK et al. (2012). Cerebrolysin, a mixture of neurotrophic factors induces marked neuroprotection in… [PMID: 22229324]

    Laboratory literature summary: Cerebrolysin, a mixture of neurotrophic factors induces marked neuroprotection in spinal cord injury following intoxication of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  92. Yang B et al. (2023). Optimized approach for active peptides identification in Cerebrolysin by nanoLC-MS [PMID: 37220681]

    Laboratory literature summary: Optimized approach for active peptides identification in Cerebrolysin by nanoLC-MS. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  93. Sharma A et al. (2019). Sleep deprivation exacerbates concussive head injury induced brain pathology:… [PMID: 30961865]

    Laboratory literature summary: Sleep deprivation exacerbates concussive head injury induced brain pathology: Neuroprotective effects of nanowired delivery of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  94. Teng H et al. (2021). Investigational effect of Cerebrolysin on reducing impaired cerebral endothelial cell… [PMID: 33661804]

    Laboratory literature summary: investigational effect of Cerebrolysin on reducing impaired cerebral endothelial cell permeability. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  95. Morales-Medina JC et al. (2019). Cerebrolysin improves peripheral inflammatory pain: Sex differences in two models of… [PMID: 30908710]

    Laboratory literature summary: Cerebrolysin improves peripheral inflammatory pain: Sex differences in two models of acute and chronic mechanical hypersensitivity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  96. Masliah E et al. (2012). The pharmacology of neurotrophic investigation with Cerebrolysin: brain protection and… [PMID: 22514792]

    Laboratory literature summary: The pharmacology of neurotrophic investigation with Cerebrolysin: brain protection and repair to counteract pathologies of acute and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  97. Jeon H et al. (2024). Laboratory research record on Cerebrolysin [PMID: 39113920]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  98. Muresanu DF et al. (2020). Laboratory research record on Cerebrolysin [PMID: 33223037]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  99. Formichi P et al. (2012). Cerebrolysin administration reduces oxidative stress-induced apoptosis in lymphocytes… [PMID: 22882711]

    Laboratory literature summary: Cerebrolysin administration reduces oxidative stress-induced apoptosis in lymphocytes from healthy individuals. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  100. Poon W et al. (2020). Laboratory research record on Cerebrolysin [PMID: 31494820]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  101. Dong HY et al. (2016). Laboratory research record on Cerebrolysin [PMID: 26981106]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  102. Morega S et al. (2021). Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage [PMID: 34942925]

    Laboratory literature summary: Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  103. Tharwat EK et al. (2023). Evaluation of the investigational potential of cerebrolysin and/or lithium in the… [PMID: 36847968]

    Laboratory literature summary: Evaluation of the investigational potential of cerebrolysin and/or lithium in the research models Wistar rat model of neurodegeneration…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  104. Alzoubi KH et al. (2018). Prevention of memory impairment induced by post-traumatic stress disorder by cerebrolysin [PMID: 30316170]

    Laboratory literature summary: Prevention of memory impairment induced by post-traumatic stress disorder by cerebrolysin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  105. Zhang C et al. (2010). Laboratory research record on Cerebrolysin [PMID: 20857512]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  106. Sharma S et al. (2022). Protective effects of cerebrolysin against chemotherapy (carmustine) induced cognitive… [PMID: 34674598]

    Laboratory literature summary: Protective effects of cerebrolysin against chemotherapy (carmustine) induced cognitive impairment in Albino mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  107. Masliah E et al. (1999). Cerebrolysin ameliorates performance deficits, and neuronal damage in apolipoprotein… [PMID: 9972690]

    Laboratory literature summary: Cerebrolysin ameliorates performance deficits, and neuronal damage in apolipoprotein E-deficient mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  108. Poon W et al. (2015). Cerebrolysin Asian Pacific trial in acute brain injury and neurorecovery: design and… [PMID: 25222349]

    Laboratory literature summary: Cerebrolysin Asian Pacific trial in acute brain injury and neurorecovery: design and methods. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  109. Park YK et al. (2018). Cerebrolysin for the investigation of Aneurysmal Subarachnoid Hemorrhage in Adults: A… [PMID: 30414051]

    Laboratory literature summary: Cerebrolysin for the investigation of Aneurysmal Subarachnoid Hemorrhage in Adults: A Retrospective Chart Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  110. Baran H et al. (2009). Cerebrolysin lowers kynurenic acid formation–an in vitro study [PMID: 19008081]

    Laboratory literature summary: Cerebrolysin lowers kynurenic acid formation–an in vitro study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  111. Muresanu DF et al. (2023). Nanowired Delivery of Cerebrolysin with Mesenchymal Stem Cells Attenuates Heat… [PMID: 37480463]

    Laboratory literature summary: Nanowired Delivery of Cerebrolysin with Mesenchymal Stem Cells Attenuates Heat Stress-Induced Exacerbation of Neuropathology Following…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  112. Selezneva ND et al. (2023). [Cerebrolysin investigation Reduces the Risk of Mild Cognitive Decline to Dementia in… [PMID: 37655416]

    Laboratory literature summary: [Cerebrolysin investigation Reduces the Risk of Mild Cognitive Decline to Dementia in 1st-Degree Relatives of neurodegeneration research…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  113. Jarosz K et al. (2024). The Effects of Neuromonitoring and Cerebrolysin Administration on Outcomes in research… [PMID: 38256487]

    Laboratory literature summary: The Effects of Neuromonitoring and Cerebrolysin Administration on Outcomes in research subjects with Traumatic Brain Injury-An…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  114. Espinoza I et al. (2024). Laboratory research record on Cerebrolysin [PMID: 38897418]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  115. Staszewski J et al. (2022). Laboratory research record on Cerebrolysin [PMID: 35860483]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  116. Mitrović SZ et al. (2023). Laboratory research record on Cerebrolysin [PMID: 36837492]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  117. Gorbachevskaya N et al. (2001). Cerebrolysin research protocol in Rett syndrome: laboratory and EEG mapping study [PMID: 11738849]

    Laboratory literature summary: Cerebrolysin research protocol in Rett syndrome: laboratory and EEG mapping study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  118. Martínez-Torres NI et al. (2024). Laboratory research record on Cerebrolysin [PMID: 38048977]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  119. Martinez RM (2017). Laboratory research record on Cerebrolysin [PMID: 29075344]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  120. Mureșanu IA et al. (2022). The Effect of Cerebrolysin on Anxiety, Depression, and Cognition in Moderate and… [PMID: 35630065]

    Laboratory literature summary: The Effect of Cerebrolysin on Anxiety, Depression, and Cognition in Moderate and Severe Traumatic Brain Injury research subjects: A…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  121. Allam AFA et al. (2018). Laboratory research record on Cerebrolysin [PMID: 29155000]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  122. Chemer N et al. (2019). Laboratory research record on Cerebrolysin [PMID: 30778859]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  123. Xing S et al. (2014). Cerebrolysin reduces amyloid-β deposits, apoptosis and autophagy in the thalamus and… [PMID: 24315581]

    Laboratory literature summary: Cerebrolysin reduces amyloid-β deposits, apoptosis and autophagy in the thalamus and improves functional recovery after cortical infarction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  124. Kalinin MN et al. (2023). Heterogeneous investigation effects of Cerebrolysin as an early add-on to reperfusion… [PMID: 38249342]

    Laboratory literature summary: Heterogeneous investigation effects of Cerebrolysin as an early add-on to reperfusion research protocol: post hoc analysis of the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  125. Farajdokht F et al. (2022). Cerebrolysin® and Environmental Enrichment, Alone or in Combination, Ameliorate… [PMID: 35500360]

    Laboratory literature summary: Cerebrolysin® and Environmental Enrichment, Alone or in Combination, Ameliorate Anxiety- and Depressive-Like Behaviors in a…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  126. Sharma A et al. (2017). Novel investigation Strategies Using TiO(2)-Nanowired Delivery of Histaminergic Drugs… [PMID: 29132541]

    Laboratory literature summary: Novel investigation Strategies Using TiO(2)-Nanowired Delivery of Histaminergic Drugs and Antibodies to Tau With Cerebrolysin for…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  127. Solis-Gaspar C et al. (2016). Cerebrolysin improves memory and ameliorates neuronal atrophy in spontaneously… [PMID: 27164468]

    Laboratory literature summary: Cerebrolysin improves memory and ameliorates neuronal atrophy in spontaneously hypertensive, aged rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  128. Lu W et al. (2022). Cerebrolysin alleviates early brain injury after traumatic brain injury by inhibiting… [PMID: 36074398]

    Laboratory literature summary: Cerebrolysin alleviates early brain injury after traumatic brain injury by inhibiting neuroinflammation and apoptosis via TLR signaling…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  129. Wiklund L et al. (2023). TiO(2)-Nanowired Delivery of Chinese Extract of Ginkgo biloba EGb-761 and Bilobalide… [PMID: 37480466]

    Laboratory literature summary: TiO(2)-Nanowired Delivery of Chinese Extract of Ginkgo biloba EGb-761 and Bilobalide BN-52021 Enhanced Neuroprotective Effects of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  130. Hosseini L et al. (2023). Synergistic effects of combined research protocol with cerebrolysin and enriched… [PMID: 36853847]

    Laboratory literature summary: Synergistic effects of combined research protocol with cerebrolysin and enriched environment on anxiety-like behavior and spatial…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  131. Ponomareva EV et al. (2024). [Cerebrolysin in the preventive research protocol of dementia in elderly research… [PMID: 39435777]

    Laboratory literature summary: [Cerebrolysin in the preventive research protocol of dementia in elderly research subjects with mild cognitive impairment: a three-year…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  132. Martínez-Torres NI et al. (2024). Acute Combined Cerebrolysin and Nicotinamide Administration Promote Cognitive Recovery… [PMID: 38734304]

    Laboratory literature summary: Acute Combined Cerebrolysin and Nicotinamide Administration Promote Cognitive Recovery Through Neuronal Changes in the Hippocampus of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  133. Mallory M et al. (1999). In vitro synaptotrophic effects of Cerebrolysin in NT2N cells [PMID: 10334480]

    Laboratory literature summary: In vitro synaptotrophic effects of Cerebrolysin in NT2N cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  134. Poljakovic Z et al. (2021). Laboratory research record on Cerebrolysin [PMID: 34214867]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  135. Chang WH et al. (2021). Laboratory research record on Cerebrolysin [PMID: 34208352]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  136. Sharma HS et al. (2021). Neurodegeneration research models's disease neuropathology is exacerbated following… [PMID: 34560919]

    Laboratory literature summary: neurodegeneration research models's disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  137. Sharma A et al. (2020). Mild traumatic brain injury exacerbates neurodegeneration research models's disease… [PMID: 33223035]

    Laboratory literature summary: Mild traumatic brain injury exacerbates neurodegeneration research models's disease induced hemeoxygenase-2 expression and brain…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  138. Zhang L et al. (2013). Laboratory research record on Cerebrolysin [PMID: 23696546]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  139. Abdel-Salam OM et al. (2013). Cerebrolysin attenuates cerebral and hepatic injury due to lipopolysaccharide in rats [PMID: 24423658]

    Laboratory literature summary: Cerebrolysin attenuates cerebral and hepatic injury due to lipopolysaccharide in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  140. Zhang L et al. (2017). Laboratory research record on Cerebrolysin [PMID: 28382851]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  141. Sharma A et al. (2012). Superior neuroprotective effects of cerebrolysin in nanoparticle-induced exacerbation… [PMID: 22229316]

    Laboratory literature summary: Superior neuroprotective effects of cerebrolysin in nanoparticle-induced exacerbation of hyperthermia-induced brain pathology. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  142. Hamed SA et al. (2023). Laboratory research record on Cerebrolysin [PMID: 37950370]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  143. Pourmemar E et al. (2017). Intranasal Cerebrolysin Attenuates Learning and Memory Impairments in… [PMID: 27894939]

    Laboratory literature summary: Intranasal Cerebrolysin Attenuates Learning and Memory Impairments in D-galactose-Induced Senescence in Mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  144. Sherif RN (2017). Laboratory research record on Cerebrolysin [PMID: 29107328]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  145. P A et al. (2024). Neuroprotection by Cerebrolysin and Citicoline Through the Upregulation of… [PMID: 38524067]

    Laboratory literature summary: Neuroprotection by Cerebrolysin and Citicoline Through the Upregulation of Brain-Derived Neurotrophic Factor (BDNF) Expression in the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  146. Elhessy HM et al. (2023). Comparative neuroprotective effects of Cerebrolysin, dexamethasone, and ascorbic acid… [PMID: 36816518]

    Laboratory literature summary: Comparative neuroprotective effects of Cerebrolysin, dexamethasone, and ascorbic acid on sciatic nerve injury model: Behavioral and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  147. Guan X et al. (2019). Cerebrolysin Ameliorates Focal Cerebral Ischemia Injury Through Neuroinflammatory… [PMID: 31695614]

    Laboratory literature summary: Cerebrolysin Ameliorates Focal Cerebral Ischemia Injury Through Neuroinflammatory Inhibition via CREB/PGC-1α Pathway. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  148. Finsterer J (2024). A positive effect of Cerebrolysin on motor functions and spasticity in ALS with limb… [PMID: 38813358]

    Laboratory literature summary: A positive effect of Cerebrolysin on motor functions and spasticity in ALS with limb or bulbar onset is questionable. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  149. Firstenfeld AJ (2024). A positive effect of Cerebrolysin on motor functions and spasticity in ALS with limb… [PMID: 38813353]

    Laboratory literature summary: A positive effect of Cerebrolysin on motor functions and spasticity in ALS with limb or bulbar onset is questionable. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  150. Sahib S et al. (2020). Cerebrolysin enhances spinal cord conduction and reduces blood-spinal cord barrier… [PMID: 33223040]

    Laboratory literature summary: Cerebrolysin enhances spinal cord conduction and reduces blood-spinal cord barrier breakdown, edema formation, immediate early gene…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  151. Khasanova DR et al. (2023). Laboratory research record on Cerebrolysin [PMID: 37682097]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  152. Bajenaru O et al. (2010). Laboratory research record on Cerebrolysin [PMID: 20968198]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  153. Veinbergs I et al. (2000). Neurotrophic effects of Cerebrolysin in animal models of excitotoxicity [PMID: 10961439]

    Laboratory literature summary: Neurotrophic effects of Cerebrolysin in animal models of excitotoxicity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  154. Sanchez-Vega L et al. (2015). Laboratory research record on Cerebrolysin [PMID: 25851531]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  155. Sharma A et al. (2023). Sleep deprivation enhances amyloid beta peptide, p-tau and serotonin in the brain:… [PMID: 37783554]

    Laboratory literature summary: Sleep deprivation enhances amyloid beta peptide, p-tau and serotonin in the brain: Neuroprotective effects of nanowired delivery of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  156. Stepanichev M et al. (2017). Effects of cerebrolysin on nerve growth factor system in the aging rat brain [PMID: 29172008]

    Laboratory literature summary: Effects of cerebrolysin on nerve growth factor system in the aging rat brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  157. Marghani BH et al. (2023). The Effect of Cerebrolysin in an Animal Model of Forebrain Ischemic-Reperfusion… [PMID: 37569457]

    Laboratory literature summary: The Effect of Cerebrolysin in an Animal Model of Forebrain Ischemic-Reperfusion Injury: New Insights into the Activation of the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  158. Bae CY et al. (2000). A double-blind, control arm-controlled, multicenter study of Cerebrolysin for… [PMID: 11129744]

    Laboratory literature summary: A double-blind, control arm-controlled, multicenter study of Cerebrolysin for neurodegeneration research models's disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  159. Ghavipanjeh G et al. (2025). Radioprotective effect of Cerebrolysin in the Rat's Brain Tissues [PMID: 38676482]

    Laboratory literature summary: Radioprotective effect of Cerebrolysin in the Rat's Brain Tissues. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  160. Rockenstein E et al. (2014). Cerebrolysin™ observed endpoints in a transgenic model of tauopathy: role in… [PMID: 25047000]

    Laboratory literature summary: Cerebrolysin™ observed endpoints in a transgenic model of tauopathy: role in regulation of mitochondrial structure. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  161. Guekht AB et al. (2011). Laboratory research record on Cerebrolysin [PMID: 20656516]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  162. Zhang L et al. (2016). Laboratory research record on Cerebrolysin [PMID: 26763925]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  163. Alvarez XA et al. (2022). Modulation of Amyloid-β and Tau in neurodegeneration research models's Disease Plasma… [PMID: 36155516]

    Laboratory literature summary: Modulation of Amyloid-β and Tau in neurodegeneration research models's Disease Plasma Neuronal-Derived Extracellular Vesicles by…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  164. Kim JY et al. (2019). Laboratory research record on Cerebrolysin [PMID: 31428035]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  165. Sharma HS et al. (2012). Neuroprotective effects of cerebrolysin, a combination of different active fragments… [PMID: 22748833]

    Laboratory literature summary: Neuroprotective effects of cerebrolysin, a combination of different active fragments of neurotrophic factors and peptides on the whole…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  166. Cuevas-Olguin R et al. (2017). Cerebrolysin prevents deficits in social behavior, repetitive conduct, and synaptic… [PMID: 28609577]

    Laboratory literature summary: Cerebrolysin prevents deficits in social behavior, repetitive conduct, and synaptic inhibition in a rat model of autism. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  167. Stan A et al. (2017). Laboratory research record on Cerebrolysin [PMID: 29362596]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  168. Mahmoudi J et al. (2018). Cerebrolysin attenuates hyperalgesia, photophobia, and neuroinflammation in a… [PMID: 29752991]

    Laboratory literature summary: Cerebrolysin attenuates hyperalgesia, photophobia, and neuroinflammation in a nitroglycerin-induced migraine model in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  169. Georgy GS et al. (2013). Laboratory research record on Cerebrolysin [PMID: 23840309]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  170. Sharma HS et al. (2014). The role of functionalized magnetic iron oxide nanoparticles in the central nervous… [PMID: 24730284]

    Laboratory literature summary: The role of functionalized magnetic iron oxide nanoparticles in the central nervous system injury and repair: new potentials for…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  171. Sharma A et al. (2023). Laboratory research record on Cerebrolysin [PMID: 36730671]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  172. Ardjmand A et al. (2019). Ameliorative effects of cerebrolysin against isoproterenol-induced myocardial injury… [PMID: 31028802]

    Laboratory literature summary: Ameliorative effects of cerebrolysin against isoproterenol-induced myocardial injury in research models rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  173. Zhang Y et al. (2020). Laboratory research record on Cerebrolysin [PMID: 31491768]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  174. Zhang Y et al. (2013). Improvement in functional recovery with administration of Cerebrolysin after… [PMID: 23581594]

    Laboratory literature summary: Improvement in functional recovery with administration of Cerebrolysin after experimental closed head injury. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  175. Espinoza I et al. (2025). Cerebrolysin investigation improved short-term memory deficits while simultaneously… [PMID: 39826813]

    Laboratory literature summary: Cerebrolysin investigation improved short-term memory deficits while simultaneously increasing hippocampal spine density in hypertensive…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  176. Haggag MA et al. (2022). Sustained Release In Situ Thermogelling Hydrogel of Cerebrolysin for investigation of… [PMID: 35041809]

    Laboratory literature summary: Sustained Release In Situ Thermogelling Hydrogel of Cerebrolysin for investigation of Facial Nerve Axotomy in Rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  177. Khalili H et al. (2017). Effects of cerebrolysin on functional recovery in research subjects with severe… [PMID: 27871029]

    Laboratory literature summary: Effects of cerebrolysin on functional recovery in research subjects with severe disability after traumatic brain injury: A historical…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  178. Alvarez XA et al. (2020). Serum VEGF Predicts laboratory Improvement Induced by Cerebrolysin Plus Donepezil in… [PMID: 32640027]

    Laboratory literature summary: Serum VEGF Predicts laboratory Improvement Induced by Cerebrolysin Plus Donepezil in research subjects With Advanced neurodegeneration…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  179. Navrotskaya V et al. (2014). Cerebrolysin Accelerates Metamorphosis and Attenuates Aging-Accelerating Effect of… [PMID: 25798213]

    Laboratory literature summary: Cerebrolysin Accelerates Metamorphosis and Attenuates Aging-Accelerating Effect of High Temperature in Drosophila Melanogaster. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  180. Xiao S et al. (2012). Laboratory research record on Cerebrolysin [PMID: 22311531]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  181. Sharma A et al. (2022). Laboratory research record on Cerebrolysin [PMID: 34889883]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  182. Muresanu DF et al. (2020). Observed endpoints and laboratory profile of cerebrolysin in neurorecovery after… [PMID: 31897941]

    Laboratory literature summary: observed endpoints and laboratory profile of cerebrolysin in neurorecovery after moderate-severe traumatic brain injury: results from…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  183. Kurkin DV et al. (2021). Neuroprotective action of Cortexin, Cerebrolysin and Actovegin in acute or chronic… [PMID: 34260655]

    Laboratory literature summary: Neuroprotective action of Cortexin, Cerebrolysin and Actovegin in acute or chronic brain ischemia in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  184. Jianu DC et al. (2010). Laboratory research record on Cerebrolysin [PMID: 20945821]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  185. Ghaffarpasand F et al. (2019). Effects of cerebrolysin on functional outcome of research subjects with traumatic… [PMID: 30643411]

    Laboratory literature summary: Effects of cerebrolysin on functional outcome of research subjects with traumatic brain injury: a systematic review and meta-analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  186. Sharma A et al. (2023). Spinal cord injury induced exacerbation of neurodegeneration research models's disease… [PMID: 37833015]

    Laboratory literature summary: Spinal cord injury induced exacerbation of neurodegeneration research models's disease like pathophysiology is reduced by topical…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  187. Heiss WD et al. (2012). Laboratory research record on Cerebrolysin [PMID: 22282884]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  188. Shmonin AA et al. (2026). [The effect of Cerebrolysin on the development of skills in research subjects after… [PMID: 41782528]

    Laboratory literature summary: [The effect of Cerebrolysin on the development of skills in research subjects after acute cerebrovascular accidents]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  189. Strilciuc S et al. (2025). Cost-effectiveness of Cerebrolysin as an add-on investigation for neurorecovery after… [PMID: 40405935]

    Laboratory literature summary: Cost-effectiveness of Cerebrolysin as an add-on investigation for neurorecovery after traumatic brain injury. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  190. Alrabadi B et al. (2026). Cerebrolysin and Risk of Hemorrhagic Transformation: A Pooled Analysis of Recent Studies [PMID: 41775380]

    Laboratory literature summary: Cerebrolysin and Risk of Hemorrhagic Transformation: A Pooled Analysis of Recent Studies. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  191. Sharma HS et al. (2023). Stress induced exacerbation of neurodegeneration research models's disease brain… [PMID: 37783559]

    Laboratory literature summary: Stress induced exacerbation of neurodegeneration research models's disease brain pathology is thwarted by co-administration of nanowired…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  192. ElBassiouny A et al. (2025). Laboratory research record on Cerebrolysin [PMID: 40027163]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  193. Staszewski J et al. (2026). Laboratory research record on Cerebrolysin [PMID: 41739286]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  194. Hosseini L et al. (2025). Cerebrolysin ameliorates ketamine-mediated anxiety and cognitive impairments via… [PMID: 41204270]

    Laboratory literature summary: Cerebrolysin ameliorates ketamine-mediated anxiety and cognitive impairments via modulation of mitochondrial function and CREB/PGC-1α…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  195. Toader LE et al. (2018). Cerebrolysin increases motor recovery and decreases inflammation in a mouse model of… [PMID: 30534814]

    Laboratory literature summary: Cerebrolysin increases motor recovery and decreases inflammation in a mouse model of autoimmune encephalitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  196. Vaghef L et al. (2019). Cerebrolysin attenuates ethanol-induced spatial memory impairments through inhibition… [PMID: 30981808]

    Laboratory literature summary: Cerebrolysin attenuates ethanol-induced spatial memory impairments through inhibition of hippocampal oxidative stress and apoptotic cell…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  197. Afridi A et al. (2026). Laboratory research record on Cerebrolysin [PMID: 41880098]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  198. Calderón Guzmán D et al. (2016). Effect of cerebrolysin on dopaminergic neurodegeneration of rat with oxidative stress… [PMID: 27383892]

    Laboratory literature summary: Effect of cerebrolysin on dopaminergic neurodegeneration of rat with oxidative stress induced by 3-nitropropionic acid. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  199. Amiri-Nikpour MR et al. (2014). Laboratory research record on Cerebrolysin [PMID: 25516711]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  200. Sotnikova NY et al. (2000). Immunoactive Properties of Cerebrolysin [PMID: 12687163]

    Laboratory literature summary: Immunoactive Properties of Cerebrolysin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  201. Levin OS et al. (2023). [Cognitive impairment and tactics of using the drug Cerebrolysin. Resolution of the… [PMID: 37796079]

    Laboratory literature summary: [Cognitive impairment and tactics of using the drug Cerebrolysin. Resolution of the International Council of Experts (May 12, 2023)]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  202. Schlager P et al. (2025). Combined citicoline and Cerebrolysin for neuroprotection in traumatic brain injury: a… [PMID: 41409218]

    Laboratory literature summary: Combined citicoline and Cerebrolysin for neuroprotection in traumatic brain injury: a retrospective cohort analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  203. El-Marasy SA et al. (2021). Anti-depressant effect of cerebrolysin in reserpine-induced depression in rats:… [PMID: 33279466]

    Laboratory literature summary: Anti-depressant effect of cerebrolysin in reserpine-induced depression in rats: Behavioral, biochemical, molecular and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  204. Chutko LS et al. (2017). [The observed endpoints of cerebrolysin in the investigation of autism spectrum disorders] [PMID: 29053124]

    Laboratory literature summary: [The observed endpoints of cerebrolysin in the investigation of autism spectrum disorders]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  205. Karimian A et al. (2025). The Role of Cerebrolysin in Promoting Axonal Regeneration and Functional Recovery… [PMID: 41835059]

    Laboratory literature summary: The Role of Cerebrolysin in Promoting Axonal Regeneration and Functional Recovery after Peripheral Nerve Injury: A Focus on Macrophage…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  206. Zamudio SR et al. (2019). Subchronic cerebrolysin investigation alleviates cognitive impairments and dendritic… [PMID: 31207446]

    Laboratory literature summary: Subchronic cerebrolysin investigation alleviates cognitive impairments and dendritic arborization alterations of granular neurons in the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  207. Chen CC et al. (2013). Laboratory research record on Cerebrolysin [PMID: 23656173]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  208. Kurkin DV et al. (2021). [Antioxidant effect of cortexin, cerebrolysin and actovegin in rats with chronic… [PMID: 34460162]

    Laboratory literature summary: [Antioxidant effect of cortexin, cerebrolysin and actovegin in rats with chronic cerebrovascular insufficiency]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  209. Lee YS et al. (2025). Laboratory research record on Cerebrolysin [PMID: 41178897]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  210. Tao Y et al. (2021). The neuroprotection of cerebrolysin after spontaneous intracerebral hemorrhage through… [PMID: 34817023]

    Laboratory literature summary: The neuroprotection of cerebrolysin after spontaneous intracerebral hemorrhage through regulates necroptosis via Akt/ GSK3β signaling…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  211. Ghavimi H et al. (2018). Attenuation of Morphine-Induced Tolerance and Dependence by Pretreatment with… [PMID: 28847022]

    Laboratory literature summary: Attenuation of Morphine-Induced Tolerance and Dependence by Pretreatment with Cerebrolysin in research models rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  212. Mahmoudi J et al. (2019). The induced decrease in TLR2 and TLR4 by cerebrolysin in the alcoholic liver of rats [PMID: 30756376]

    Laboratory literature summary: The induced decrease in TLR2 and TLR4 by cerebrolysin in the alcoholic liver of rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  213. Guzmán DC et al. (2009). Cerebrolysin and morphine decrease glutathione and 5-hydroxyindole acetic acid levels… [PMID: 18993027]

    Laboratory literature summary: Cerebrolysin and morphine decrease glutathione and 5-hydroxyindole acetic acid levels in fasted rat brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  214. Ladurner G et al. (2005). Laboratory research record on Cerebrolysin [PMID: 15583955]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  215. Rockenstein E et al. (2003). The neuroprotective effects of Cerebrolysin in a transgenic model of neurodegeneration… [PMID: 14628195]

    Laboratory literature summary: The neuroprotective effects of Cerebrolysin in a transgenic model of neurodegeneration research models's disease are associated with…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  216. Rockenstein E et al. (2006). Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor… [PMID: 16511867]

    Laboratory literature summary: Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  217. Safarova ER et al. (2002). Trophic effects of nootropic peptide preparations cerebrolysin and semax on cultured… [PMID: 12124658]

    Laboratory literature summary: Trophic effects of nootropic peptide preparations cerebrolysin and semax on cultured rat pheochromocytoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  218. Sharma HS et al. (2021). Cerebrolysin restores balance between excitatory and inhibitory amino acids in brain… [PMID: 34689860]

    Laboratory literature summary: Cerebrolysin restores balance between excitatory and inhibitory amino acids in brain following concussive head injury. Superior…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  219. Biesenbach G et al. (1997). Laboratory research record on Cerebrolysin [PMID: 9173675]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  220. Ren J et al. (2007). Cerebrolysin enhances functional recovery following focal cerebral infarction in rats [PMID: 17473393]

    Laboratory literature summary: Cerebrolysin enhances functional recovery following focal cerebral infarction in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  221. Noor NA et al. (2016). A promising investigational potential of cerebrolysin in 6-OHDA rat model of… [PMID: 27210889]

    Laboratory literature summary: A promising investigational potential of cerebrolysin in 6-OHDA rat model of neurodegeneration research models's disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  222. Requejo C et al. (2018). Nanodelivery of Cerebrolysin and Rearing in Enriched Environment Induce… [PMID: 28840482]

    Laboratory literature summary: Nanodelivery of Cerebrolysin and Rearing in Enriched Environment Induce Neuroprotective Effects in a Preclinical Rat Model of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  223. Domzał T et al. (1995). Laboratory research record on Cerebrolysin [PMID: 7566407]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  224. Ozkizilcik A et al. (2018). Timed Release of Cerebrolysin Using Drug-Loaded Titanate Nanospheres Reduces Brain… [PMID: 28875428]

    Laboratory literature summary: Timed Release of Cerebrolysin Using Drug-Loaded Titanate Nanospheres Reduces Brain Pathology and Improves Behavioral Functions in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  225. Chanubol R et al. (2021). Laboratory research record on Cerebrolysin [PMID: 34493699]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  226. Yang Y et al. (2016). Attenuation of Acute Phase Injury in Rat Intracranial Hemorrhage by Cerebrolysin that… [PMID: 26498936]

    Laboratory literature summary: Attenuation of Acute Phase Injury in Rat Intracranial Hemorrhage by Cerebrolysin that Inhibits Brain Edema and Inflammatory Response. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  227. Sharma HS et al. (2021). Laboratory research record on Cerebrolysin [PMID: 34689862]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  228. Nasiri J et al. (2017). Effect of cerebrolysin on gross motor function of children with cerebral palsy: a… [PMID: 28074392]

    Laboratory literature summary: Effect of cerebrolysin on gross motor function of children with cerebral palsy: a laboratory trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  229. Park YK et al. (2019). Correction to: Cerebrolysin for the investigation of Aneurysmal Subarachnoid… [PMID: 30900197]

    Laboratory literature summary: Correction to: Cerebrolysin for the investigation of Aneurysmal Subarachnoid Hemorrhage in Adults: A Retrospective Chart Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  230. Stadnik A et al. (2025). Effect of Cerebrolysin on Cognitive Function and Delirium in Coronary Artery Bypass… [PMID: 40350671]

    Laboratory literature summary: Effect of Cerebrolysin on Cognitive Function and Delirium in Coronary Artery Bypass Graft research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  231. Rockenstein E et al. (2015). Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of… [PMID: 26611895]

    Laboratory literature summary: Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  232. Hassanein SM et al. (2016). Laboratory research record on Cerebrolysin [PMID: 26365023]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  233. Cárdenas-Bedoya J et al. (2025). Laboratory research record on Cerebrolysin [PMID: 40123021]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  234. Rockenstein E et al. (2015). Neuro-peptide investigation with Cerebrolysin improves the survival of neural stem… [PMID: 26209890]

    Laboratory literature summary: Neuro-peptide investigation with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  235. Huang TL et al. (2014). Protective effects of cerebrolysin in a rat model of optic nerve crush [PMID: 24924838]

    Laboratory literature summary: Protective effects of cerebrolysin in a rat model of optic nerve crush. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  236. Liu Z et al. (2017). Cerebrolysin alleviates cognitive deficits induced by chronic cerebral hypoperfusion… [PMID: 28458021]

    Laboratory literature summary: Cerebrolysin alleviates cognitive deficits induced by chronic cerebral hypoperfusion by increasing the levels of plasticity-related…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  237. Lee S et al. (2020). Additive effect of cerebrolysin and amantadine on disorders of consciousness secondary… [PMID: 32057086]

    Laboratory literature summary: Additive effect of cerebrolysin and amantadine on disorders of consciousness secondary to acquired brain injury: A retrospective…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  238. Alvarez XA et al. (2000). Oral Cerebrolysin enhances brain alpha activity and improves cognitive performance in… [PMID: 10961443]

    Laboratory literature summary: Oral Cerebrolysin enhances brain alpha activity and improves cognitive performance in elderly control subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  239. Sharma HS et al. (2010). Cerebrolysin reduces blood-cerebrospinal fluid barrier permeability change, brain… [PMID: 20633118]

    Laboratory literature summary: Cerebrolysin reduces blood-cerebrospinal fluid barrier permeability change, brain pathology, and functional deficits following traumatic…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  240. Author et al. (2025). Laboratory research record on Cerebrolysin [PMID: 39869713]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  241. Gevaert B et al. (2015). Peptide profiling of Internet-obtained Cerebrolysin using high performance liquid… [PMID: 26017115]

    Laboratory literature summary: Peptide profiling of Internet-obtained Cerebrolysin using high performance liquid chromatography – electrospray ionization ion trap and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  242. Wong GK et al. (2005). Beneficial effect of cerebrolysin on moderate and severe head injury research… [PMID: 16463821]

    Laboratory literature summary: Beneficial effect of cerebrolysin on moderate and severe head injury research subjects: result of a cohort study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  243. Kojder K et al. (2023). Noninvasive monitoring in a research subjects with SAH analytical assessment studied… [PMID: 37522695]

    Laboratory literature summary: Noninvasive monitoring in a research subjects with SAH analytical assessment studied with Cerebrolysin – case report and review of the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  244. Kalinin MN et al. (2025). Laboratory research record on Cerebrolysin [PMID: 40123141]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  245. Sadigh-Eteghad S et al. (2018). Intranasal cerebrolysin improves cognitive function and structural synaptic plasticity… [PMID: 30054019]

    Laboratory literature summary: Intranasal cerebrolysin improves cognitive function and structural synaptic plasticity in photothrombotic mouse model of medial…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  246. Hutter-Paier B et al. (1998). Cerebrolysin protects isolated cortical neurons from neurodegeneration after brief… [PMID: 9700671]

    Laboratory literature summary: Cerebrolysin protects isolated cortical neurons from neurodegeneration after brief histotoxic hypoxia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  247. Alvarez XA et al. (2011). Laboratory research record on Cerebrolysin [PMID: 21679156]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  248. Kandasamy G et al. (2025). Laboratory research record on Cerebrolysin [PMID: 41010922]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  249. Sidorenko EI et al. (1995). [Cerebrolysin in the investigation of partial optic atrophy in children] [PMID: 7571926]

    Laboratory literature summary: [Cerebrolysin in the investigation of partial optic atrophy in children]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  250. Rockenstein E et al. (2025). Retraction Note: Cerebrolysin™ observed endpoints in a transgenic model of tauopathy:… [PMID: 41382024]

    Laboratory literature summary: Retraction Note: Cerebrolysin™ observed endpoints in a transgenic model of tauopathy: role in regulation of mitochondrial structure. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  251. Formichi P et al. (2013). Effects of cerebrolysin administration on oxidative stress-induced apoptosis in… [PMID: 22878905]

    Laboratory literature summary: Effects of cerebrolysin administration on oxidative stress-induced apoptosis in lymphocytes from CADASIL research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  252. Doppler E et al. (2026). Retraction Note: Neurotrophic effects of Cerebrolysin in the Mecp2(308/Y) transgenic… [PMID: 41874695]

    Laboratory literature summary: Retraction Note: Neurotrophic effects of Cerebrolysin in the Mecp2(308/Y) transgenic model of Rett syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  253. Rockenstein E et al. (2007). Effects of Cerebrolysin on neurogenesis in an APP transgenic model of… [PMID: 17131129]

    Laboratory literature summary: Effects of Cerebrolysin on neurogenesis in an APP transgenic model of neurodegeneration research models's disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  254. Gromova OA et al. (2019). [An analysis of the peptide composition of a 'light' peptide fraction of cerebrolysin] [PMID: 31626174]

    Laboratory literature summary: [An analysis of the peptide composition of a 'light' peptide fraction of cerebrolysin]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  255. Alvarez XA et al. (2016). Synergistic Increase of Serum BDNF in neurodegeneration research models research… [PMID: 27207906]

    Laboratory literature summary: Synergistic Increase of Serum BDNF in neurodegeneration research models research subjects studied with Cerebrolysin and Donepezil:…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  256. Alcántara-González F et al. (2012). Combined administration of cerebrolysin and donepezil induces plastic changes in… [PMID: 22826038]

    Laboratory literature summary: Combined administration of cerebrolysin and donepezil induces plastic changes in prefrontal cortex in aged mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  257. Kalinin MN et al. (2025). Laboratory research record on Cerebrolysin [PMID: 41640685]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  258. Vázquez-Roque RA et al. (2014). Chronic cerebrolysin administration attenuates neuronal abnormalities in the… [PMID: 24123373]

    Laboratory literature summary: Chronic cerebrolysin administration attenuates neuronal abnormalities in the basolateral amygdala induced by neonatal ventral…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  259. Gharagozli K et al. (2017). Laboratory research record on Cerebrolysin [PMID: 29075343]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  260. Patocková J et al. (2003). Cerebrolysin inhibits lipid peroxidation induced by insulin hypoglycemia in the brain… [PMID: 12899658]

    Laboratory literature summary: Cerebrolysin inhibits lipid peroxidation induced by insulin hypoglycemia in the brain and heart of mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  261. Hien NM et al. (2019). Laboratory research record on Cerebrolysin [PMID: 31666824]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  262. Ubhi K et al. (2013). Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and… [PMID: 23152192]

    Laboratory literature summary: Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  263. Ruozi B et al. (2015). PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation… [PMID: 26108180]

    Laboratory literature summary: PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  264. Doppler E et al. (2008). Neurotrophic effects of Cerebrolysin in the Mecp2(308/Y) transgenic model of Rett syndrome [PMID: 18600331]

    Laboratory literature summary: Neurotrophic effects of Cerebrolysin in the Mecp2(308/Y) transgenic model of Rett syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  265. Poon W et al. (2020). Laboratory research record on Cerebrolysin [PMID: 31909448]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  266. Teng H et al. (2026). Exosomes Released by Cerebrolysin-studied Cerebral Endothelial Cells Reverse Fibrin-… [PMID: 42193943]

    Laboratory literature summary: Exosomes Released by Cerebrolysin-studied Cerebral Endothelial Cells Reverse Fibrin- or tPA-Impaired Endothelial Cell Permeability. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  267. Trojanová M et al. (1976). Influence of cerebrolysin(r) on the resistance of rats to anoxia [PMID: 135987]

    Laboratory literature summary: Influence of cerebrolysin(r) on the resistance of rats to anoxia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  268. Vilenskiĭ BS (1997). [Cerebrolysin in neurological and psychiatric practice] [PMID: 9589960]

    Laboratory literature summary: [Cerebrolysin in neurological and psychiatric practice]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  269. Woo PYM et al. (2020). Laboratory research record on Cerebrolysin [PMID: 33143640]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  270. Boshra V et al. (2016). Effect of cerebrolysin on oxidative stress-induced apoptosis in an experimental rat… [PMID: 28229640]

    Laboratory literature summary: Effect of cerebrolysin on oxidative stress-induced apoptosis in an experimental rat model of myocardial ischemia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  271. Ardjmand A et al. (2019). Cardioprotective effects of cerebrolysin on the lesion severity and inflammatory… [PMID: 31201967]

    Laboratory literature summary: Cardioprotective effects of cerebrolysin on the lesion severity and inflammatory factors in a rat model of isoproterenol-induced…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  272. Birle C et al. (2020). The Effect of Cerebrolysin on the Predictive Value of Baseline Prognostic Risk Score… [PMID: 33072197]

    Laboratory literature summary: The Effect of Cerebrolysin on the Predictive Value of Baseline Prognostic Risk Score in Moderate and Severe Traumatic Brain Injury. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  273. Gromova OA et al. (2005). [Vitamin activity of cerebrolysin] [PMID: 15952541]

    Laboratory literature summary: [Vitamin activity of cerebrolysin]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  274. Yari-Ilkhchi A et al. (2024). Design and synthesis of nano-biomaterials based on graphene and local delivery of… [PMID: 38298594]

    Laboratory literature summary: Design and synthesis of nano-biomaterials based on graphene and local delivery of cerebrolysin into the injured spinal cord of mice,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  275. Hutter-Paier B et al. (1996). Death of cultured telencephalon neurons induced by glutamate is reduced by the peptide… [PMID: 8841972]

    Laboratory literature summary: Death of cultured telencephalon neurons induced by glutamate is reduced by the peptide derivative Cerebrolysin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  276. Sharma A et al. (2020). Concussive head injury exacerbates neuropathology of sleep deprivation: Superior… [PMID: 33223033]

    Laboratory literature summary: Concussive head injury exacerbates neuropathology of sleep deprivation: Superior neuroprotection by co-administration of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  277. Sotnikova NY et al. (2002). Dual effect of cerebrolysin in children with attention deficit syndrome with… [PMID: 12687248]

    Laboratory literature summary: Dual effect of cerebrolysin in children with attention deficit syndrome with hyperactivity: neuroprotection and immunomodulation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  278. Panisset M et al. (2002). Laboratory research record on Cerebrolysin [PMID: 12111446]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  279. Rockenstein E et al. (2025). Retraction Note: Neuroprotective effects of Cerebrolysin in triple repeat Tau… [PMID: 40065222]

    Laboratory literature summary: Retraction Note: Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  280. Kofler B et al. (1990). A multidimensional approach in testing nootropic drug effects (Cerebrolysin) [PMID: 15374509]

    Laboratory literature summary: A multidimensional approach in testing nootropic drug effects (Cerebrolysin). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  281. Gusev EI et al. (2007). Laboratory research record on Cerebrolysin [PMID: 18477976]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  282. Zhang L et al. (2019). Laboratory research record on Cerebrolysin [PMID: 30665068]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  283. Hartbauer M et al. (2001). Effects of Cerebrolysin on the outgrowth and protection of processes of cultured brain… [PMID: 11459078]

    Laboratory literature summary: Effects of Cerebrolysin on the outgrowth and protection of processes of cultured brain neurons. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  284. Kalinin MN et al. (2025). Laboratory research record on Cerebrolysin [PMID: 40577185]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  285. Onose G et al. (2009). Neuroprotective and consequent neurorehabilitative laboratory outcomes, in research… [PMID: 20108748]

    Laboratory literature summary: Neuroprotective and consequent neurorehabilitative laboratory outcomes, in research subjects studied with the pleiotropic drug cerebrolysin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  286. Rockenstein E et al. (2015). Neuropeptide investigation with Cerebrolysin Enhances the Survival of Grafted Neural… [PMID: 27429559]

    Laboratory literature summary: Neuropeptide investigation with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  287. Lucas B et al. (2014). Effects of cerebrolysin on rat Schwann cells in vitro [PMID: 24636538]

    Laboratory literature summary: Effects of cerebrolysin on rat Schwann cells in vitro. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  288. Loukavenko EA et al. (2016). Impaired spatial working memory after anterior thalamic lesions: recovery with… [PMID: 25725627]

    Laboratory literature summary: Impaired spatial working memory after anterior thalamic lesions: recovery with cerebrolysin and enrichment. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  289. Selezneva ND et al. (2020). [Delayed effects of cerebrolysin in the prevention of cognitive impairment progression… [PMID: 33205928]

    Laboratory literature summary: [Delayed effects of cerebrolysin in the prevention of cognitive impairment progression in the first degree relatives of research…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  290. Kobayashi A et al. (2025). Laboratory research record on Cerebrolysin [PMID: 41180520]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  291. Sharma HS et al. (2018). Co-Administration of TiO2 Nanowired Mesenchymal Stem Cells with Cerebrolysin… [PMID: 28844104]

    Laboratory literature summary: Co-Administration of TiO2 Nanowired Mesenchymal Stem Cells with Cerebrolysin Potentiates Neprilysin Level and Reduces Brain Pathology in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  292. Athari SZ et al. (2025). Synergistic Effects of Cerebrolysin and Aerobic Exercise on 6-hydroxydopamine-induced… [PMID: 42382515]

    Laboratory literature summary: Synergistic Effects of Cerebrolysin and Aerobic Exercise on 6-hydroxydopamine-induced Model of neurodegeneration research models Disease…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  293. Khabirov FA et al. (2016). [Effect of cerebrolysin on remyelination processes in multiple sclerosis research… [PMID: 28139626]

    Laboratory literature summary: [Effect of cerebrolysin on remyelination processes in multiple sclerosis research subjects in stage of relapse regression]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  294. Alvarez XA et al. (2003). Positive effects of cerebrolysin on electroencephalogram slowing, cognition and… [PMID: 12920387]

    Laboratory literature summary: Positive effects of cerebrolysin on electroencephalogram slowing, cognition and laboratory outcome in research subjects with postacute…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  295. Rockenstein E et al. (2002). Effects of Cerebrolysin on amyloid-beta deposition in a transgenic model of… [PMID: 12456076]

    Laboratory literature summary: Effects of Cerebrolysin on amyloid-beta deposition in a transgenic model of neurodegeneration research models's disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  296. Xue LX et al. (2016). Laboratory research record on Cerebrolysin [PMID: 27168844]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  297. Belokrylov GA et al. (1992). [Levamin and cerebrolysin as immunostimulants] [PMID: 1611065]

    Laboratory literature summary: [Levamin and cerebrolysin as immunostimulants]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  298. Akbari-Gharalari N et al. (2026). Cerebrolysin-loaded platelet-rich plasma exosomes: Restoring immune homeostasis via… [PMID: 40470992]

    Laboratory literature summary: Cerebrolysin-loaded platelet-rich plasma exosomes: Restoring immune homeostasis via TNF-α/IL-10 modulation and apoptosis targeting for…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  299. Funke M et al. (1998). Exposure level-dependent effects of Cerebrolysin on EEG and short-term memory of… [PMID: 9700674]

    Laboratory literature summary: exposure level-dependent effects of Cerebrolysin on EEG and short-term memory of healthy research subjects during control and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  300. Sharma HS et al. (2011). Laboratory research record on Cerebrolysin [PMID: 22097459]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  301. Sharma HS et al. (2011). Cerebrolysin Attenuates Heat Shock Protein (HSP 72 KD) Expression in the Rat Spinal… [PMID: 21886595]

    Laboratory literature summary: Cerebrolysin Attenuates Heat Shock Protein (HSP 72 KD) Expression in the Rat Spinal Cord Following Morphine Dependence and Withdrawal:…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  302. Talypov AE et al. (2014). [Cerebrolysin in the investigation of brain injuries of moderate severity] [PMID: 25591645]

    Laboratory literature summary: [Cerebrolysin in the investigation of brain injuries of moderate severity]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  303. Boontoterm P et al. (2026). Neuroprotective Effects of Cerebrolysin in Moderate Traumatic Brain Injury with… [PMID: 42110924]

    Laboratory literature summary: Neuroprotective Effects of Cerebrolysin in Moderate Traumatic Brain Injury with Nonoperative Lesions: A 6-Month Prospective Cohort Analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  304. Gromova OA et al. (2015). [Pharmacokinetic and pharmacodynamic synergism between neuropeptides and lithium in… [PMID: 26120985]

    Laboratory literature summary: [Pharmacokinetic and pharmacodynamic synergism between neuropeptides and lithium in the neurotrophic and neuroprotective action of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  305. Gschanes A et al. (2000). The drug cerebrolysin and its peptide fraction E021 increase the abundance of the… [PMID: 10816070]

    Laboratory literature summary: The drug cerebrolysin and its peptide fraction E021 increase the abundance of the blood-brain barrier GLUT1 glucose transporter in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  306. Ubhi K et al. (2009). Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with… [PMID: 19252918]

    Laboratory literature summary: Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  307. Medvecký J et al. (1982). [Findings in investigation with cerebrolysin] [PMID: 7172295]

    Laboratory literature summary: [Findings in investigation with cerebrolysin]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  308. Rainer M et al. (1997). Investigational results with Cerebrolysin in the investigation of dementia [PMID: 9408984]

    Laboratory literature summary: investigational results with Cerebrolysin in the investigation of dementia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  309. Zhang Y et al. (2018). Laboratory research record on Cerebrolysin [PMID: 29303438]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  310. Tyurenkov IN et al. (2020). [Comparative study of protective effects of Cortexin, Cerebrolysin and Actovegin on… [PMID: 32929929]

    Laboratory literature summary: [Comparative study of protective effects of Cortexin, Cerebrolysin and Actovegin on memory impairment, cerebral circulation and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  311. Juárez I et al. (2011). The chronic administration of cerebrolysin induces plastic changes in the prefrontal… [PMID: 21544867]

    Laboratory literature summary: The chronic administration of cerebrolysin induces plastic changes in the prefrontal cortex and dentate gyrus in aged mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  312. Krauss W (1975). [laboratory experience with Cerebrolysin in geriatrics] [PMID: 1186482]

    Laboratory literature summary: [laboratory experience with Cerebrolysin in geriatrics]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  313. Kapoor S (2013). Cerebrolysin and its emerging laboratory applications in psychiatry [PMID: 23405015]

    Laboratory literature summary: Cerebrolysin and its emerging laboratory applications in psychiatry. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  314. Gothe M (1974). [research protocol with Cerebrolysin, a parenterally administered organ hydrolysate] [PMID: 4839021]

    Laboratory literature summary: [research protocol with Cerebrolysin, a parenterally administered organ hydrolysate]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  315. Ruether E et al. (2001). A 28-week, double-blind, control arm-controlled study with Cerebrolysin in research… [PMID: 11552768]

    Laboratory literature summary: A 28-week, double-blind, control arm-controlled study with Cerebrolysin in research subjects with mild to moderate neurodegeneration…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  316. Hartbauer M et al. (2001). Antiapoptotic effects of the peptidergic drug cerebrolysin on primary cultures of… [PMID: 11475013]

    Laboratory literature summary: Antiapoptotic effects of the peptidergic drug cerebrolysin on primary cultures of embryonic chick cortical neurons. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  317. Alvarez XA et al. (2000). Cerebrolysin reduces microglial activation in vivo and in vitro: a potential mechanism… [PMID: 10961440]

    Laboratory literature summary: Cerebrolysin reduces microglial activation in vivo and in vitro: a potential mechanism of neuroprotection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  318. Muresanu DF et al. (2010). Persistence of the effects of Cerebrolysin on cognition and qEEG slowing in vascular… [PMID: 20923712]

    Laboratory literature summary: Persistence of the effects of Cerebrolysin on cognition and qEEG slowing in vascular dementia research subjects: results of a 3-month…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  319. Borisevich A et al. (2021). Laboratory research record on Cerebrolysin [PMID: 34594556]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  320. González JDSR et al. (2025). Surgical excision of cerebral glioma and multimodal investigation including… [PMID: 41532044]

    Laboratory literature summary: Surgical excision of cerebral glioma and multimodal investigation including Cerebrolysin: a case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  321. Gromova OA et al. (2006). [An oligopeptide membrane fraction of cerebrolysin] [PMID: 16921723]

    Laboratory literature summary: [An oligopeptide membrane fraction of cerebrolysin]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  322. Shabanov PD et al. (2007). Comparison of behavioral effects of cortexin and cerebrolysin injected into brain… [PMID: 18214294]

    Laboratory literature summary: Comparison of behavioral effects of cortexin and cerebrolysin injected into brain ventricles. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  323. Sharma HS et al. (2010). Cerebrolysin attenuates blood-brain barrier and brain pathology following whole body… [PMID: 19812972]

    Laboratory literature summary: Cerebrolysin attenuates blood-brain barrier and brain pathology following whole body hyperthermia in the rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  324. Valousková V et al. (1998). Can Cerebrolysin influence chronic deterioration of spatial learning and memory? [PMID: 9700670]

    Laboratory literature summary: Can Cerebrolysin influence chronic deterioration of spatial learning and memory?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  325. Vázquez-Roque RA et al. (2012). Chronic administration of the neurotrophic agent cerebrolysin ameliorates the… [PMID: 21932359]

    Laboratory literature summary: Chronic administration of the neurotrophic agent cerebrolysin ameliorates the behavioral and morphological changes induced by neonatal…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  326. Alvarez XA et al. (2011). Laboratory research record on Cerebrolysin [PMID: 20500802]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  327. Sharma HS et al. (2025). Retraction Note to: Co-Administration of TiO2 Nanowired Mesenchymal Stem Cells with… [PMID: 39707122]

    Laboratory literature summary: Retraction Note to: Co-Administration of TiO2 Nanowired Mesenchymal Stem Cells with Cerebrolysin Potentiates Neprilysin Level and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  328. Chutko LS et al. (2015). [laboratory and electroencephalographic characteristics of specific language… [PMID: 26356521]

    Laboratory literature summary: [laboratory and electroencephalographic characteristics of specific language impairment in children and an evaluation of the observed…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  329. Maksimova MIu et al. (2009). Laboratory research record on Cerebrolysin [PMID: 19156082]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  330. Sharma HS et al. (2026). Retraction Note: Cerebrolysin Attenuates Exacerbation of Neuropathic Pain,… [PMID: 42143192]

    Laboratory literature summary: Retraction Note: Cerebrolysin Attenuates Exacerbation of Neuropathic Pain, Blood-Spinal Cord Barrier Breakdown and Cord Pathology…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  331. Panteleeva GP et al. (1999). [Cerebrolysin and magnesium-B6 in the investigation of observed outcomes in study models of psychotropic drugs] [PMID: 11530457]

    Laboratory literature summary: [Cerebrolysin and magnesium-B6 in the investigation of observed outcomes in study models of psychotropic drugs]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  332. Haninec P et al. (2004). Reinnervation of the rat musculocutaneous nerve stump after its direct reconnection… [PMID: 15351925]

    Laboratory literature summary: Reinnervation of the rat musculocutaneous nerve stump after its direct reconnection with the C5 spinal cord segment by the nerve graft…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  333. Hong Z et al. (2009). Laboratory research record on Cerebrolysin [PMID: 19765131]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  334. Alvarez XA et al. (2008). Reductions in qEEG slowing over 1 year and after investigation with Cerebrolysin in… [PMID: 18273537]

    Laboratory literature summary: Reductions in qEEG slowing over 1 year and after investigation with Cerebrolysin in research subjects with moderate-severe traumatic…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  335. Schwab M et al. (1997). Physiological effects and brain protection by hypothermia and cerebrolysin after… [PMID: 9085084]

    Laboratory literature summary: Physiological effects and brain protection by hypothermia and cerebrolysin after moderate forebrain ischemia in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  336. Serkina EV et al. (2008). [Cerebrolysin alleviates perinatal CNS disorders through the autoimmune modulation and… [PMID: 19008804]

    Laboratory literature summary: [Cerebrolysin alleviates perinatal CNS disorders through the autoimmune modulation and antioxidant protection]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  337. Shishkova VN et al. (2015). Laboratory research record on Cerebrolysin [PMID: 26356162]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  338. Muresanu DF et al. (2015). A retrospective, multi-center cohort study evaluating the severity- related effects of… [PMID: 25924999]

    Laboratory literature summary: A retrospective, multi-center cohort study evaluating the severity- related effects of cerebrolysin investigation on laboratory outcomes…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  339. Lang W et al. (2013). Laboratory research record on Cerebrolysin [PMID: 23009193]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  340. Author et al. (2026). Retraction: Regional Comparison of the Neurogenic Effects of CNTF-Derived Peptides and… [PMID: 42015030]

    Laboratory literature summary: Retraction: Regional Comparison of the Neurogenic Effects of CNTF-Derived Peptides and Cerebrolysin in AβPP Transgenic Mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  341. Muresanu DF et al. (2008). A pilot study to evaluate the effects of Cerebrolysin on cognition and qEEG in… [PMID: 18048059]

    Laboratory literature summary: A pilot study to evaluate the effects of Cerebrolysin on cognition and qEEG in vascular dementia: cognitive improvement correlates with…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  342. Sharma HS et al. (2010). Cerebrolysin investigation attenuates heat shock protein overexpression in the brain… [PMID: 20633119]

    Laboratory literature summary: Cerebrolysin investigation attenuates heat shock protein overexpression in the brain following heat stress: an experimental study using…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  343. Lombardi VR et al. (1999). Effects of Cerebrolysin on in vitro primary microglial and astrocyte rat cell cultures [PMID: 10420388]

    Laboratory literature summary: Effects of Cerebrolysin on in vitro primary microglial and astrocyte rat cell cultures. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  344. Berezhnaya SV et al. (2016). [The observed endpoints of combination research protocol with mexidol and cerebrolysin… [PMID: 27240176]

    Laboratory literature summary: [The observed endpoints of combination research protocol with mexidol and cerebrolysin in chronic cerebral ischemia]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  345. Rüther E et al. (1994). Observed endpoints of the peptidergic nootropic drug cerebrolysin in research subjects… [PMID: 8159781]

    Laboratory literature summary: observed endpoints of the peptidergic nootropic drug cerebrolysin in research subjects with senile dementia of the neurodegeneration…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  346. Kositsyn NS et al. (2006). [observed endpoints of cerebrolysin in cerebral hemorrhage model in rats] [PMID: 17209460]

    Laboratory literature summary: [observed endpoints of cerebrolysin in cerebral hemorrhage model in rats]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  347. Ozkizilcik A et al. (2026). Retraction Note to: Timed Release of Cerebrolysin Using Drug-Loaded Titanate… [PMID: 41920231]

    Laboratory literature summary: Retraction Note to: Timed Release of Cerebrolysin Using Drug-Loaded Titanate Nanospheres Reduces Brain Pathology and Improves Behavioral…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  348. Muresanu DF et al. (2019). Laboratory research record on Cerebrolysin [PMID: 31349933]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  349. González ME et al. (1998). Antioxidant systemic effect of short-term Cerebrolysin administration [PMID: 9700669]

    Laboratory literature summary: Antioxidant systemic effect of short-term Cerebrolysin administration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  350. Alvarez XA et al. (2006). A 24-week, double-blind, control arm-controlled study of three dosages of Cerebrolysin… [PMID: 16420392]

    Laboratory literature summary: A 24-week, double-blind, control arm-controlled study of three dosages of Cerebrolysin in research subjects with mild to moderate…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  351. Gromova OA et al. (2014). [Mechanisms of neurotrophic and neuroprotective effects of cerebrolysin in cerebral… [PMID: 24781241]

    Laboratory literature summary: [Mechanisms of neurotrophic and neuroprotective effects of cerebrolysin in cerebral ischemia]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  352. Schwab M et al. (1997). Morphofunctional effects of moderate forebrain ischemia combined with short-term… [PMID: 9085071]

    Laboratory literature summary: Morphofunctional effects of moderate forebrain ischemia combined with short-term hypoxia in rats–protective effects of Cerebrolysin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  353. Haninec P et al. (2003). Rescue of rat spinal motoneurons from avulsion-induced cell death by intrathecal… [PMID: 12801087]

    Laboratory literature summary: Rescue of rat spinal motoneurons from avulsion-induced cell death by intrathecal administration of IGF-I and Cerebrolysin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  354. Valousková V et al. (1999). Effects of NGF, b-FGF, and cerebrolysin on water maze performance and on motor… [PMID: 10082636]

    Laboratory literature summary: Effects of NGF, b-FGF, and cerebrolysin on water maze performance and on motor activity of rats: short- and long-term study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  355. Damulin IV et al. (2008). Effects of cerebrolysin on moderate cognitive impairments in cerebral vascular… [PMID: 18607744]

    Laboratory literature summary: Effects of cerebrolysin on moderate cognitive impairments in cerebral vascular insufficiency (a laboratory-electrophysiological study). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  356. Skwortsova VI et al. (2006). Laboratory research record on Cerebrolysin [PMID: 18196634]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  357. Schauer E et al. (2006). Neuroprotection of cerebrolysin in tissue culture models of brain ischemia: post… [PMID: 16362636]

    Laboratory literature summary: Neuroprotection of cerebrolysin in tissue culture models of brain ischemia: post lesion application indicates a wide investigational window. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  358. Polushin AY et al. (2017). [The observed endpoints of prevention of postoperative cognitive dysfunction in… [PMID: 29376982]

    Laboratory literature summary: [The observed endpoints of prevention of postoperative cognitive dysfunction in cardiac surgeries with the use of the cerebrolysin]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  359. Rockenstein E et al. (2011). Regional comparison of the neurogenic effects of CNTF-derived peptides and… [PMID: 21860085]

    Laboratory literature summary: Regional comparison of the neurogenic effects of CNTF-derived peptides and cerebrolysin in AβPP transgenic mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  360. Hutter-Paier B et al. (1996). Cerebrolysin protects neurons from ischemia-induced loss of microtubule–associated… [PMID: 8841974]

    Laboratory literature summary: Cerebrolysin protects neurons from ischemia-induced loss of microtubule–associated protein 2. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  361. Ubhi K et al. (2026). Editorial Expression of Concern: Neurofibrillary and neurodegenerative pathology in… [PMID: 41817815]

    Laboratory literature summary: Editorial Expression of Concern: Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU:…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  362. Damulin IV et al. (2007). [Cerebrolysin investigation of mild cognitive impairment of vascular genesis] [PMID: 17684971]

    Laboratory literature summary: [Cerebrolysin investigation of mild cognitive impairment of vascular genesis]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  363. Khatkova SE et al. (2026). Laboratory research record on Cerebrolysin [PMID: 41661016]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  364. Eder P et al. (2001). Increased density of glutamate receptor subunit 1 due to Cerebrolysin investigation:… [PMID: 12197668]

    Laboratory literature summary: Increased density of glutamate receptor subunit 1 due to Cerebrolysin investigation: an immunohistochemical study on aged rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  365. Hoang Ngoc N et al. (2020). Using low-exposure level tissue plasminogen activator through external ventricular… [PMID: 33489233]

    Laboratory literature summary: Using low-exposure level tissue plasminogen activator through external ventricular drain and Cerebrolysin for the investigation of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  366. sadin AV et al. (2013). [A study of neuroregenerative action of cerebrolysin in brain trauma] [PMID: 23739443]

    Laboratory literature summary: [A study of neuroregenerative action of cerebrolysin in brain trauma]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  367. Iakupov EZ et al. (2014). Laboratory research record on Cerebrolysin [PMID: 25345642]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  368. Rezaei Y et al. (2016). Laboratory research record on Cerebrolysin [PMID: 27056986]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  369. Krasnoperova MG et al. (2003). [The effect of cerebrolysin on cognitive functions in childhood autism and in Asperger… [PMID: 12872620]

    Laboratory literature summary: [The effect of cerebrolysin on cognitive functions in childhood autism and in Asperger syndrome]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  370. Zhovnir IK et al. (1973). [Use of cerebrolysin in research subjects with cerebral arteriosclerosis] [PMID: 4786906]

    Laboratory literature summary: [Use of cerebrolysin in research subjects with cerebral arteriosclerosis]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  371. Sugita Y et al. (1993). [Protective effect of FPF 1070 (cerebrolysin) on delayed neuronal death in the… [PMID: 8334017]

    Laboratory literature summary: [Protective effect of FPF 1070 (cerebrolysin) on delayed neuronal death in the gerbil–detection of hydroxyl radicals with salicylic acid]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  372. Rybnikova EA et al. (2013). [A comparison of a neuroprotective effects of hypoxic postconditioning and… [PMID: 23528584]

    Laboratory literature summary: [A comparison of a neuroprotective effects of hypoxic postconditioning and cerebrolysin in the experimental model]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  373. Rockenstein E et al. (2005). Amelioration of the cerebrovascular amyloidosis in a transgenic model of… [PMID: 15657642]

    Laboratory literature summary: Amelioration of the cerebrovascular amyloidosis in a transgenic model of neurodegeneration research models's disease with the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  374. Gutmann B et al. (2002). In vitro models of brain ischemia: the peptidergic drug cerebrolysin protects cultured… [PMID: 12826494]

    Laboratory literature summary: In vitro models of brain ischemia: the peptidergic drug cerebrolysin protects cultured chick cortical neurons from cell death. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  375. Sadin AV et al. (2001). [Cerebrovascular and renal effects of cerebrolysin and dependence on salt intake] [PMID: 11871236]

    Laboratory literature summary: [Cerebrovascular and renal effects of cerebrolysin and dependence on salt intake]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  376. Gruzman AV et al. (1998). [The effect of cerebrolysin intravenous parenteral-route administration in resistant… [PMID: 9845942]

    Laboratory literature summary: [The effect of cerebrolysin intravenous parenteral-route administration in resistant forms of night enuresis in children]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  377. Vester JC et al. (2017). Laboratory research record on Cerebrolysin [PMID: 29051220]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  378. Bereczki D (2017). Laboratory research record on Cerebrolysin [PMID: 29051221]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  379. Vereshchagin NV et al. (1991). [Mild forms of multi-infarct dementia: effectiveness of cerebrolysin] [PMID: 1767322]

    Laboratory literature summary: [Mild forms of multi-infarct dementia: effectiveness of cerebrolysin]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  380. Shamalov NA et al. (2010). Laboratory research record on Cerebrolysin [PMID: 21626816]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  381. Vereshchagin NV et al. (2001). Laboratory research record on Cerebrolysin [PMID: 11494441]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  382. Zhivolupov SA et al. (2011). [The сomparative analysis of neyromidin and cerebrolysin effects on neurodynamic… [PMID: 21512498]

    Laboratory literature summary: [The сomparative analysis of neyromidin and cerebrolysin effects on neurodynamic processes during craniocerebral injury]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  383. Muresanu DF et al. (2010). Chronic hypertension aggravates heat stress-induced brain damage: possible… [PMID: 19812973]

    Laboratory literature summary: Chronic hypertension aggravates heat stress-induced brain damage: possible neuroprotection by cerebrolysin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  384. Alvarez XA et al. (2009). Reduced TNF-α and increased IGF-I levels in the serum of neurodegeneration research… [PMID: 19531281]

    Laboratory literature summary: Reduced TNF-α and increased IGF-I levels in the serum of neurodegeneration research models's disease research subjects studied with the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  385. Skvortsova VI et al. (2004). Laboratory research record on Cerebrolysin [PMID: 15559222]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  386. Satou T et al. (2000). Neurotrophic effects of FPF-1070 (Cerebrolysin) on cultured neurons from chicken… [PMID: 11145001]

    Laboratory literature summary: Neurotrophic effects of FPF-1070 (Cerebrolysin) on cultured neurons from chicken embryo dorsal root ganglia, ciliary ganglia, and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  387. Hutter-Paier B et al. (1998). Further evidence that Cerebrolysin protects cortical neurons from neurodegeneration in… [PMID: 9700672]

    Laboratory literature summary: Further evidence that Cerebrolysin protects cortical neurons from neurodegeneration in vitro. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  388. Ruether E et al. (2002). Sustained improvement of cognition and global function in research subjects with… [PMID: 12456069]

    Laboratory literature summary: Sustained improvement of cognition and global function in research subjects with moderately severe neurodegeneration research models's…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  389. Kontsevoĭ VA et al. (1997). [Use of cerebrolysin in the investigation of prolonged extrapyramidal complications of… [PMID: 11517474]

    Laboratory literature summary: [Use of cerebrolysin in the investigation of prolonged extrapyramidal complications of neuroleptic research protocol]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  390. Naĭdin VL et al. (1993). [Cerebrolysin electrophoresis in the correction of the mental defects in neurosurgery… [PMID: 8296505]

    Laboratory literature summary: [Cerebrolysin electrophoresis in the correction of the mental defects in neurosurgery research subjects]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  391. Zemková H et al. (1995). Potentiation of GABAA receptor in cultured mouse hippocampal cells by brain-derived… [PMID: 8869271]

    Laboratory literature summary: Potentiation of GABAA receptor in cultured mouse hippocampal cells by brain-derived peptide mixture cerebrolysin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  392. Gannushkina IV et al. (1998). [Effect of the nootropic agent cerebrolysin in cerebral ischemia in rats with varying… [PMID: 9633187]

    Laboratory literature summary: [Effect of the nootropic agent cerebrolysin in cerebral ischemia in rats with varying behavioral reactions in the open field test]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  393. Ruozi B et al. (2014). Poly (D,L-lactide-co-glycolide) nanoparticles loaded with cerebrolysin display… [PMID: 25106629]

    Laboratory literature summary: Poly (D,L-lactide-co-glycolide) nanoparticles loaded with cerebrolysin display neuroprotective activity in a rat model of concussive…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  394. Le VC et al. (2021). Laboratory research record on Cerebrolysin [PMID: 33796315]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  395. Rüther E et al. (2000). Sustained improvements in research subjects with dementia of neurodegeneration… [PMID: 11005546]

    Laboratory literature summary: Sustained improvements in research subjects with dementia of neurodegeneration research models's type (DAT) 6 months after termination…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  396. Koppi S et al. (1998). Laboratory research record on Cerebrolysin [PMID: 9819885]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  397. Gromova OA et al. (1998). [Effects of cerebrolysin on the oxidant homeostasis, the content of microelements and… [PMID: 9505400]

    Laboratory literature summary: [Effects of cerebrolysin on the oxidant homeostasis, the content of microelements and electrolytes in children with minimal brain…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  398. Schwab M et al. (1996). Effects of Cerebrolysin on cytoskeletal proteins after focal ischemia in rats [PMID: 8841977]

    Laboratory literature summary: Effects of Cerebrolysin on cytoskeletal proteins after focal ischemia in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  399. Roshchina IF et al. (1999). [The influence of cerebrolysin on the efficiency of subsequent research protocol with… [PMID: 10629930]

    Laboratory literature summary: [The influence of cerebrolysin on the efficiency of subsequent research protocol with amiridine++ in neurodegeneration research models's…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  400. Gschanes A et al. (1996). The influence of Cerebrolysin and E021 on spatial navigation of young rats [PMID: 8841976]

    Laboratory literature summary: The influence of Cerebrolysin and E021 on spatial navigation of young rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  401. Bayer E (1980). [research protocol with the cerebral hydrolysate cerebrolysin. A practice report] [PMID: 7191468]

    Laboratory literature summary: [research protocol with the cerebral hydrolysate cerebrolysin. A practice report]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  402. Gschanes A et al. (1998). The influence of Cerebrolysin and E021 on spatial navigation of 24-month-old rats [PMID: 9700667]

    Laboratory literature summary: The influence of Cerebrolysin and E021 on spatial navigation of 24-month-old rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  403. Francis-Turner L et al. (1996). Nerve growth factor and nootropic drug Cerebrolysin but not fibroblast growth factor… [PMID: 8848264]

    Laboratory literature summary: Nerve growth factor and nootropic drug Cerebrolysin but not fibroblast growth factor can reduce spatial memory impairment elicited by…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  404. Gershman RN et al. (1975). [Use of cerebrolysin and ATP in investigating infantile cerebral paralysis] [PMID: 1228606]

    Laboratory literature summary: [Use of cerebrolysin and ATP in investigating infantile cerebral paralysis]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  405. Wojtowicz JM et al. (1996). Brain tissue hydrolysate, Cerebrolysin, acts on presynaptic adenosine receptors in the… [PMID: 8841979]

    Laboratory literature summary: Brain tissue hydrolysate, Cerebrolysin, acts on presynaptic adenosine receptors in the rat hippocampus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  406. Iakhno NN et al. (1996). [Experience with using high doses of cerebrolysin in vascular dementia] [PMID: 9026950]

    Laboratory literature summary: [Experience with using high doses of cerebrolysin in vascular dementia]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  407. Gromova OA et al. (2003). [Effects of cerebrolysin on trace element homeostasis in the brain] [PMID: 14681969]

    Laboratory literature summary: [Effects of cerebrolysin on trace element homeostasis in the brain]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  408. Radzivil MG et al. (2006). [An effect of long-term cerebrolysin research protocol in combination with… [PMID: 16548370]

    Laboratory literature summary: [An effect of long-term cerebrolysin research protocol in combination with neuroleptics on behavioral and cognitive disturbances in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  409. Gavrilova SI et al. (2008). [The investigational potential of cerebrolysin in the preventive research protocol of… [PMID: 18833104]

    Laboratory literature summary: [The investigational potential of cerebrolysin in the preventive research protocol of neurodegeneration research models's disease]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  410. Bogdanov EI et al. (2009). Laboratory research record on Cerebrolysin [PMID: 19770830]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  411. Lukhanina EP et al. (2004). [Effect of cerebrolysin on the electroencephalographic indices of brain activity in… [PMID: 15347036]

    Laboratory literature summary: [Effect of cerebrolysin on the electroencephalographic indices of brain activity in neurodegeneration research models's disease]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  412. Cruz R et al. (1998). [Short-term effects of septo-hippocampal pathway transsection and cerebrolysin effects… [PMID: 9796003]

    Laboratory literature summary: [Short-term effects of septo-hippocampal pathway transsection and cerebrolysin effects on glutathione-related enzymes in the rat brain]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  413. Govorin NV et al. (2008). [The pathophysiological analysis of cerebrolysin research protocol of children with… [PMID: 18577958]

    Laboratory literature summary: [The pathophysiological analysis of cerebrolysin research protocol of children with mental developmental delay caused by ecological factors]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  414. Bogdanov EI et al. (2011). Laboratory research record on Cerebrolysin [PMID: 21350421]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  415. Gomazkov OA (2002). [4th International Symposium. "Cerebrolysin: pharmacological effects and role in… [PMID: 12378888]

    Laboratory literature summary: [4th International Symposium. "Cerebrolysin: pharmacological effects and role in laboratory practice"]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  416. Vilenskiĭ BS et al. (2000). Laboratory research record on Cerebrolysin [PMID: 11247183]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  417. Chukanova EI (2005). Laboratory research record on Cerebrolysin [PMID: 15704482]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  418. Wenzel E (1976). [The effect of cerebrolysin on chronic encephalopathy. An experimental psychological… [PMID: 825764]

    Laboratory literature summary: [The effect of cerebrolysin on chronic encephalopathy. An experimental psychological and electroencephalographic study (author's transl)]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  419. Guseva MR et al. (2005). [The efficiency of the use of cerebrolysin in optic nerve diseases in children of… [PMID: 16075623]

    Laboratory literature summary: [The efficiency of the use of cerebrolysin in optic nerve diseases in children of different age]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  420. Gavrilova SI et al. (2010). [Possibilities of preventive investigation of neurodegeneration research models's… [PMID: 20436440]

    Laboratory literature summary: [Possibilities of preventive investigation of neurodegeneration research models's disease: results of the 3-year open prospective…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  421. Shchudlo NA et al. (2013). [The effect of cerebrolysin on the regeneration of the peripheral nerve depending on… [PMID: 24430040]

    Laboratory literature summary: [The effect of cerebrolysin on the regeneration of the peripheral nerve depending on the scheme of paraneural administration]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  422. Valouskova V et al. (1996). The short-term influence of b-FGF, NGF and Cerebrolysin on the memory impaired after… [PMID: 8841978]

    Laboratory literature summary: The short-term influence of b-FGF, NGF and Cerebrolysin on the memory impaired after fimbria-fornix lesion. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  423. Zuber VL (1991). [The effect of cerebrolysin on the metabolism of brain phospholipids in growing… [PMID: 1817241]

    Laboratory literature summary: [The effect of cerebrolysin on the metabolism of brain phospholipids in growing animals with experimental demyelination]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  424. Jelasić F (1976). [laboratory experience with Cerebrolysin in severe lesions of the cerebral cortex] [PMID: 1014808]

    Laboratory literature summary: [laboratory experience with Cerebrolysin in severe lesions of the cerebral cortex]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  425. Kosmarskaia EN et al. (1980). [Effect of cerebrolysin on the function of the vestibulo-oculomotor and… [PMID: 6968055]

    Laboratory literature summary: [Effect of cerebrolysin on the function of the vestibulo-oculomotor and vestibulo-optokinetic systems in experimental postnatal…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  426. Damulin IV et al. (2007). [The effect of cerebrolysin on moderate cognitive impairment in cerebral vascular… [PMID: 18379494]

    Laboratory literature summary: [The effect of cerebrolysin on moderate cognitive impairment in cerebral vascular insufficiency (a laboratory and electrophysiological…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  427. Wanderka H (1975). [investigational influence of cerebrolysin on the long-term stress barrier after an… [PMID: 1226796]

    Laboratory literature summary: [investigational influence of cerebrolysin on the long-term stress barrier after an accident]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  428. Sütterlin F (1977). [investigation of apoplectic attack using a higher single exposure level of Cerebrolysin] [PMID: 895476]

    Laboratory literature summary: [investigation of apoplectic attack using a higher single exposure level of Cerebrolysin]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  429. Osipenko TN et al. (1991). [Local administration of cerebrolysin in Raynaud's disease in a 2-year-old child] [PMID: 1661499]

    Laboratory literature summary: [Local administration of cerebrolysin in Raynaud's disease in a 2-year-old child]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  430. Roshchina IF et al. (2005). [Neuropsychological evaluation of long-term research protocol of neurodegeneration… [PMID: 15704485]

    Laboratory literature summary: [Neuropsychological evaluation of long-term research protocol of neurodegeneration research models's disease using different…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  431. Bespalova MA et al. (1991). [The characteristics of the brain cerebrosides, sulfocerebrosides and gangliosides in… [PMID: 1817238]

    Laboratory literature summary: [The characteristics of the brain cerebrosides, sulfocerebrosides and gangliosides in experimental demyelination and cerebrolysin…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  432. Francis-Turner L et al. (1996). The long-term effect of NGF, b-FGF and Cerebrolysin on the spatial memory after… [PMID: 8841975]

    Laboratory literature summary: The long-term effect of NGF, b-FGF and Cerebrolysin on the spatial memory after fimbria-fornix lesion in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  433. Liu W et al. (2001). [Analysis of the content of ten kinds of metal elements in cerebrolysin by atomic… [PMID: 12947679]

    Laboratory literature summary: [Analysis of the content of ten kinds of metal elements in cerebrolysin by atomic absorption spectrophotometry]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  434. Deviatkina TA et al. (2000). [Characteristics of lipid peroxidation in various tissues during acute stress and its… [PMID: 11022305]

    Laboratory literature summary: [Characteristics of lipid peroxidation in various tissues during acute stress and its correction by pyracetam and cerebrolysin]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  435. Muresanu DF et al. (2002). Improved global function and activities of daily living in research subjects with AD:… [PMID: 12456070]

    Laboratory literature summary: Improved global function and activities of daily living in research subjects with AD: a control arm-controlled laboratory study with the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  436. Kofler B et al. (1990). [The usefulness of event-related negativity in demonstrating the investigational… [PMID: 2123433]

    Laboratory literature summary: [The usefulness of event-related negativity in demonstrating the investigational effects of nootropic drugs using cerebrolysin as an…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  437. Gusev EI et al. (1994). Laboratory research record on Cerebrolysin [PMID: 8009944]

    PubMed laboratory record discussing Cerebrolysin in a research context. Review the full methods and limitations on PubMed; research use only.

  438. Shtrygol' OIu et al. (2000). [The observed endpoints of different salt diets and the modulation of the protective… [PMID: 10763106]

    Laboratory literature summary: [The observed endpoints of different salt diets and the modulation of the protective action of cerebrolysin in an experimental…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

Browse the full PubMed index: PubMed search.

Additional information

Weight .125 lbs
Dimensions 9 × 7 × .5 in
Size: No selection

5 mg, 10 mg, 60 mg

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.

Frequently Asked Questions

What is Cerebrolysin?

Cerebrolysin is a peptide-based compound composed of low molecular weight peptides and amino acids. It is studied in research laboratories for its role in neurotrophic and cellular signaling pathways.

What is Cerebrolysin used for in research?

Cerebrolysin is used in research laboratories to investigate neuropeptide activity, neuronal signaling, and cellular pathway interactions. It is not approved for human use.

Is Cerebrolysin Peptide approved or intended for human use?

No. Cerebrolysin is strictly intended for research purposes only and is not approved by the FDA for human use.

Is Cerebrolysin Peptide FDA-approved for medical or clinical use?

No. Cerebrolysin is not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.

In what form is Cerebrolysin supplied?

Cerebrolysin is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories.

How should Cerebrolysin be stored?

Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.

What vial sizes are available for Cerebrolysin?

Cerebrolysin is available in multiple vial sizes (e.g., 5ml, 10ml).

Is Cerebrolysin Peptide sold as a prescription product?

No prescription is required; however, it is sold strictly for research use only.

How is Cerebrolysin shipped?

Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit. For more info, visit: https://www.nationwidepeptides.com/shipping-and-payments/

How can I verify Cerebrolysin purity and quality?

Product quality is supported through third-party laboratory testing and Certificates of Analysis (COA), confirming purity and batch consistency. For more info, visit: https://www.nationwidepeptides.com/coa/